| # | Cited nodes | Nodes / Authors | GCS | LCS |
| 11501 | 7 | 11501 1999 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 258(1):11-16
Marc N; Damon M; Fautrel A; Guillouzo A; Corcos L Isolation of a cyp2b10-like cDNA and of a clone derived from a cyp2b10-like pseudogene | 3 | 2
|
| 11502 | 23 | 11502 1999 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 258(1):32-38
Zhang YQ; Pernecky SJ Cumene hydroperoxide-supported demethylation reactions catalyzed by cytochrome P450 2B4 lacking the NH2-terminal sequence | 1 | 0
|
| 11503 | 11 | 11503 1999 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 258(1):155-161
Sabourault C; Amichot M; Pauron D; Berge JB; Lafaurie M; Girard JP Cloning of CYP4F7, a kidney-specific P450 in the sea bass Dicentrarchus labrax | 5 | 3
|
| 11504 | 11 | 11504 1999 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 259(2):305-310
Winter J; Bilbe G; Richener H; Sehringer B; Kayser H Cloning of a cDNA encoding a novel cytochrome P450 from the insect Locusta migratoria: CYP6H1, a putative ecdysone 20- hydroxylase | 16 | 6
|
| 11505 | 4 | 11505 1999 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 263(2):286-293
Hu Y; Hakkola J; Oscarson M; Ingelman-Sundberg M Structural and functional characterization of the 5 '-flanking region of the rat and human cytochrome P450 2E1 genes: Identification of a polymorphic repeat in the human gene | 19 | 2
|
| 11506 | 6 | 11506 1999 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 263(2):392-397
Osada M; Ogura Y; Yasui H; Sakurai H Involvement of singlet oxygen in cytochrome P450-dependent substrate oxidations | 4 | 0
|
| 11507 | 9 | 11507 1999 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 263(3):838-842
Taylor M; Lamb DC; Cannell R; Dawson M; Kelly SL Cytochrome P450105D1 (CYP105D1) from Streptomyces griseus: Heterologous expression, activity, and activation effects of multiple xenobiotics | 6 | 3
|
| 11508 | 25 | 11508 1999 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 264(2):413-418
Dauphin-Villemant C; Bocking D; Tom M; Maibeche M; Lafont R Cloning of a novel cytochrome P450 (CYP4C15) differentially expressed in the steroidogenic glands of an arthropod | 6 | 0
|
| 11509 | 9 | 11509 1999 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 266(1):262-267
Gu J; Dudley C; Su T; Spink DC; Zhang QY; Moss RL; Ding XX Cytochrome P450 and steroid hydroxylase activity in mouse olfactory and vomeronasal mucosa | 5 | 0
|
| 11510 | 37 | 11510 1999 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 266(3):690-698
Omura T Forty years of cytochrome P450 | 29 | 12
|
| 11511 | 10 | 11511 1999 BIOCHEMICAL JOURNAL 338():499-505
Bagnaresi P; Thoiron S; Mansion M; Rossignol M; Pupillo P; Briat JF Cloning and characterization of a maize cytochrome-b(5) reductase with Fe3+-chelate reduction capability | 7 | 0
|
| 11512 | 16 | 11512 1999 BIOCHEMICAL JOURNAL 339():371-379
Noble MA; Miles CS; Chapman SK; Lysek DA; Mackay AC; Reid GA; Hanzlik RP; Munro AW Roles of key active-site residues in flavocytochrome P450 BM3 | 17 | 13
|
| 11513 | 6 | 11513 1999 BIOCHEMICAL JOURNAL 339():695-703
Tilloy-Ellul A; Raffalli-Mathieu F; Lang MA Analysis of RNA-protein interactions of moose liver cytochrome P4502A5 mRNA | 9 | 0
|
| 11514 | 15 | 11514 1999 BIOCHEMICAL JOURNAL 340():453-458
Zhukov A; Ingelman-Sundberg M Relationship between cytochrome P450 catalytic cycling and stability: fast degradation of ethanol-inducible cytochrome P450 2E1 (CYP2E1) in hepatoma cells is abolished by inactivation of its electron donor NADPH-cytochrome P450 reductase | 11 | 2
|
| 11515 | 19 | 11515 1999 BIOCHEMICAL PHARMACOLOGY 57(5):465-480
Rodrigues AD Integrated cytochrome P450 reaction phenotyping - Attempting to bridge the gap between cDNA-expressed cytochromes P450 and native human liver microsomes | 59 | 13
|
| 11516 | 9 | 11516 1999 BIOCHEMICAL PHARMACOLOGY 57(8):951-954
Elkahwaji J; Robin MA; Berson A; Tinel M; Letteron P; Labbe G; Beaune P; Elias D; Rougier P; Escudier B; Duvillard P; Pessayre D Decrease in hepatic cytochrome P450 after interleukin-2 Immunotherapy | 9 | 1
|
| 11517 | 19 | 11517 1999 BIOCHEMICAL PHARMACOLOGY 57(12):1407-1413
Koskela S; Hakkola J; Hukkanen J; Pelkonen O; Sorri M; Saranen A; Anttila S; Fernandez-Salguero P; Gonzalez F; Raunio H Expression of CYP2A genes in human liver and extrahepatic tissues | 32 | 10
|
| 11518 | 18 | 11518 1999 BIOCHEMICAL PHARMACOLOGY 58(3):525-537
Dey A; Jones JE; Nebert DW Tissue- and cell type-specific expression of cytochrome P450 1A1 and cytochrome P450 1A2 mRNA in the mouse localized in situ hybridization | 32 | 7
|
| 11519 | 6 | 11519 1999 BIOCHEMICAL PHARMACOLOGY 58(10):1547-1555
Lee SM; Cho TS; Kim DJ; Cha YN Protective effect of ethanol against acetaminophen-induced hepatotoxicity in mice - Role of NADH : quinone reductase | 2 | 0
|
| 11520 | 13 | 11520 1999 BIOCHEMICAL SOCIETY TRANSACTIONS 27(2):190-196
Munro AW; Noble MA; Miles CS; Daff SN; Green AJ; Quaroni L; Rivers S; Ost TWB; Reid GA; Chapman SK Flavocytochrome P-450 BM3: a paradigm for the analysis of electron transfer and its control in the P-450s | 2 | 2
|
| 11521 | 14 | 11521 1999 BIOCHEMICAL SOCIETY TRANSACTIONS 27(4):387-391
Wright MC The cytochrome P450 3A4 inducer metyrapone is an activator of the human pregnane X receptor | 3 | 2
|
| 11522 | 11 | 11522 1999 BIOCHEMISTRY 38(2):751-761
Davydov DR; Hoa GHB; Peterson JA Dynamics of protein-bound water in the heme domain of P450BM3 studied by high-pressure spectroscopy: Comparison with P450cam and P450 2B4 | 8 | 3
|
| 11523 | 30 | 11523 1999 BIOCHEMISTRY 38(5):1598-1606
Brock BJ; Waterman MR Biochemical differences between rat and human cytochrome P450c17 support the different steroidogenic needs of these two species | 13 | 5
|
| 11524 | 23 | 11524 1999 BIOCHEMISTRY 38(19):6093-6103
Schalk M; Nedelkina S; Schoch G; Batard Y; Werck-Reichhart D Role of unusual amino acid residues in the proximal and distal heme regions of a plant P450, CYP73A1 | 6 | 0
|
| 11525 | 6 | 11525 1999 BIOCHEMISTRY 38(37):11961-11972
Xue LL; Wang YH; Xie Y; Yao P; Wang WH; Qian W; Huang ZX; Wu J; Xia ZX Effect of mutation at valine 61 on the three-dimensional structure, stability, and redox potential of cytochrome b(5) | 15 | 2
|
| 11526 | 13 | 11526 1999 BIOCHEMISTRY 38(37):12180-12186
Doray B; Chen CD; Kemper B Substitutions in the C-terminal portion of the catalytic domain partially reverse assembly defects introduced by mutations in the N-terminal linker sequence of cytochrome P4502C2 | 1 | 1
|
| 11527 | 8 | 11527 1999 BIOCHEMISTRY 38(41):13699-13706
Deng TJ; Proniewicz LM; Kincaid JR; Yeom H; Macdonald IDG; Sligar SG Resonance Raman studies of cytochrome P450BM3 and its complexes with exogenous ligands | 9 | 2
|
| 11528 | 10 | 11528 1999 BIOCHEMISTRY 38(48):15853-15862
Sono M; Ledbetter AP; McMillan K; Roman LJ; Shea TM; Masters BSS; Dawson JH Essential thiol requirement to restore pterin- or substrate- binding capability and to regenerate native enzyme-type high- spin heme spectra in the Escherichia coli-expressed tetrahydrobiopterin-free oxygenase domain of neuronal nitric oxide synthase | 8 | 0
|
| 11529 | 23 | 11529 1999 BIOCHEMISTRY-MOSCOW 64(2):136-152
Vinogradov AD; Gavrikova EV; Grivennikova VG; Zharova TV; Zakharova NV Catalytic properties of mitochondrial NADH-ubiquinone reductase (Complex I) | 2 | 0
|
| 11530 | 1 | 11530 1999 BIOCHEMISTRY-MOSCOW 64(5):528-542
Reutov VP Biochemical predetermination of the NO synthase and nitrite reductase components of the nitric oxide cycle | 3 | 0
|
| 11531 | 48 | 11531 1999 BIOCHEMISTRY-MOSCOW 64(7):725-737
Ivanov IV; Groza NV; Myagkova GI Cytochrome p450-dependent metabolism of arachidonic acid | 2 | 0
|
| 11532 | 16 | 11532 1999 BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION 1446(3):438-442
Tohkin M; Kurose K; Isozaki E; Fukuhara M Molecular cloning, heterologous expression, and characterization of a novel member of CYP2A in the Syrian hamster | 1 | 1
|
| 11533 | 1 | 11533 1999 BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS 1427(2):216-226
Pou S; Tsai P; Porasuphatana S; Halpern HJ; Chandramouli GVR; Barth ED; Rosen GM Spin trapping of nitric oxide by ferro-chelates: kinetic and in vivo pharmacokinetic studies | 23 | 2
|
| 11534 | 16 | 11534 1999 BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS 1441(2-3):141-149
Li HY; Poulos TL Fatty acid metabolism, conformational change, and electron transfer in cytochrome P-450(BM-3) | 10 | 6
|
| 11535 | 18 | 11535 1999 BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY 1430(1):95-102
Hsu NC; Guzov VM; Hsu LC; Chung BC Characterization of the consequence of a novel Glu-380 to Asp mutation by expression of functional P450c21 in Escherichia coli | 2 | 1
|
| 11536 | 20 | 11536 1999 BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY 1433(1-2):87-102
Lacour T; Ohkawa H Engineering and biochemical characterization of the rat microsomal cytochrome P4501A1 fused to ferredoxin and ferredoxin-NADP(+) reductase from plant chloroplasts | 5 | 4
|
| 11537 | 5 | 11537 1999 BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY 1434(1):31-43
Lepesheva GI; Strushkevich NV; Usanov SA Conformational dynamics and molecular interaction reactions of recombinant cytochrome P450scc (CYP11Al) detected by fluorescence energy transfer | 7 | 2
|
| 11538 | 4 | 11538 1999 BIOFIZIKA 44(4):624-627
Matushkin YG; Morozova IN; Morozov PS Some features of evolution of cytochromes P450 | 0 | 0
|
| 11539 | 2 | 11539 1999 BIOLOGICAL RHYTHM RESEARCH 30(4):361-370
Male T; Feder J; Giaever GN; Giaever I Oscillations in yeast observed electrically | 0 | 0
|
| 11540 | 14 | 11540 1999 BIOMARKERS 4(6):425-441
Peters LD; Shaw JP; Nott M; O'Hara SCM; Livingstone DR Development of cytochrome P450 as a biomarker of organic pollution in Mytilus sp.: field studies in United Kingdom ('Sea Empress' oil spill) and the Mediterranean Sea | 7 | 1
|
| 11541 | 2 | 11541 1999 BIOORGANIC & MEDICINAL CHEMISTRY 7(8):1487-1496
Ahmed S A novel molecular modelling study of inhibitors of the 17 alpha-hydroxylase component of the enzyme system 17 alpha- hydroxylase/17,20-lyase (P-450(17 alpha)) | 2 | 1
|
| 11542 | 3 | 11542 1999 BIOORGANIC & MEDICINAL CHEMISTRY 7(9):1913-1924
Wachall BG; Hector M; Zhuang Y; Hartmann RW Imidazole substituted biphenyls: A new class of highly potent and in vivo active inhibitors of P450 17 as potential therapeutics for treatment of prostate cancer | 15 | 3
|
| 11543 | 6 | 11543 1999 BIOORGANIC CHEMISTRY 27(2):81-90
Flitsch SL; Aitken SJ; Chow CSY; Grogan G; Staines A Biohydroxylation reactions catalyzed by enzymes and whole-cell systems | 8 | 0
|
| 11544 | 13 | 11544 1999 BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY 63(1):21-28
Hara M; Miyake J; Asada Y; Ohkawa H Purified fusion enzyme between rat cytochrome P4501A1 and yeast NADPH-cytochrome P450 oxidoreductase | 3 | 3
|
| 11545 | 6 | 11545 1999 BIOTECHNOLOGY AND BIOENGINEERING 64(3):333-341
Schneider S; Wubbolts MG; Oesterhelt G; Sanglard D; Witholt B Controlled regioselectivity of fatty acid oxidation by whole cells producing cytochrome P450(BM-3) monooxygenase under varied dissolved oxygen concentrations | 6 | 3
|
| 11546 | 1 | 11546 1999 BRAIN RESEARCH 836(1-2):62-69
Centeno JM; Orti MA; Salom JB; Sick TJ; Perez-Pinzon MA Nitric oxide is involved in anoxic preconditioning neuroprotection in rat hippocampal slices | 24 | 0
|
| 11547 | 13 | 11547 1999 BRAIN RESEARCH 842(1):139-147
Renton KW; Dibb S; Levatte TL Lipopolysaccharide evokes the modulation of brain cytochrome P4501A in the rat | 7 | 0
|
| 11548 | 4 | 11548 1999 BRITISH JOURNAL OF ANAESTHESIA 82(2):255-265
Ciccone GK; Holdcroft A Drugs and sex differences: a review of drugs relating to anaesthesia | 9 | 0
|
| 11549 | 8 | 11549 1999 BRITISH JOURNAL OF ANAESTHESIA 82(6):900-903
Oda Y; Mizutani K; Hase I; Nakamoto T; Hamaoka N; Asada A Fentanyl inhibits metabolism of midazolam: competitive inhibition of CYP3A4 in vitro | 8 | 3
|
| 11550 | 18 | 11550 1999 BRITISH JOURNAL OF CANCER 79(11-12):1836-1842
Murray GI; McFadyen MCE; Mitchell RT; Cheung YL; Kerr AC; Melvin WT Cytochrome P450CYP3A in human renal cell cancer | 12 | 3
|
| 11551 | 17 | 11551 1999 BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 48(5):716-727
Kenworthy KE; Bloomer JC; Clarke SE; Houston JB CYP3A4 drug interactions: correlation of 10 in vitro probe substrates | 53 | 11
|
| 11552 | 3 | 11552 1999 BRITISH JOURNAL OF PHARMACOLOGY 126(7):1531-1533
Thomas GP; Karmazyn M; Zygmunt AC; Antzelevitch C; Narayanan N The antifungal antibiotic clotrimazole potently inhibits L-type calcium current in guinea-pig ventricular myocytes | 7 | 1
|
| 11553 | 10 | 11553 1999 BRITISH MEDICAL BULLETIN 55(2):366-386
Wolf CR; Smith G Pharmacogenetics | 34 | 2
|
| 11554 | 3 | 11554 1999 CANADIAN JOURNAL OF CHEMICAL ENGINEERING 77(5):893-902
Sheppard JD; Dawson PSS Cell synchrony and periodic behaviour in yeast populations | 1 | 0
|
| 11555 | 3 | 11555 1999 CANADIAN JOURNAL OF FISHERIES AND AQUATIC SCIENCES 56(4):642-649
Foster EP; Curtis LR 2,2 ',4,4 ',5,5 '- and 3,3 ',4,4 ' 5,5 '- Hexachlorobiphenyl pretreatments alter the biliary excretion of a challenge dose of 7,12-[H-3]dimethylbenz[a]anthracene in rainbow trout (Oncorhyncus mykiss) | 0 | 0
|
| 11556 | 5 | 11556 1999 CANADIAN JOURNAL OF MICROBIOLOGY 45(10):833-839
Kawahara N; Ikatsu H; Kawata H; Miyoshi S; Tomochika K; Sinoda S Purification and characterization of 2-ethoxyphenol-induced cytochrome P450 from Corynebacterium sp strain EP1 | 1 | 0
|
| 11557 | 14 | 11557 1999 CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY 77(8):589-597
Di Re J; Lee C; Riddick DS Lack of mechanism-based inactivation of rat hepatic microsomal cytochromes P450 by doxorubicin | 2 | 0
|
| 11558 | 7 | 11558 1999 CANADIAN MEDICAL ASSOCIATION JOURNAL 161(10):1281-1286
Herman RJ Drug interactions and the statins | 25 | 2
|
| 11559 | 1 | 11559 1999 CANCER CAUSES & CONTROL 10(1):1-11
Dorgan JF; Brock JW; Rothman N; Needham LL; Miller R; Stephenson HE; Schussler N; Taylor PR Serum organochlorine pesticides and PCBs and breast cancer risk: results from a prospective analysis (USA) | 44 | 0
|
| 11560 | 7 | 11560 1999 CANCER CHEMOTHERAPY AND PHARMACOLOGY 43(1):59-67
Philip PA; Ali-Sadat S; Doehmer J; Kocarek T; Akhtar A; Lu H; Chan KK Use of V79 cells with stably transfected cytochrome P450 cDNAs in studying the metabolism and effects of cytotoxic drugs | 9 | 0
|
| 11561 | 5 | 11561 1999 CANCER LETTERS 138(1-2):73-79
Tateishi T; Nakura H; Asoh M; Watanabe M; Tanaka M; Kumai T; Kobayashi S Multiple cytochrome P-450 subfamilies are co-induced with P- glycoprotein by both phenothiazine and 2-acetylaminofluorene in rats | 9 | 0
|
| 11562 | 8 | 11562 1999 CANCER LETTERS 138(1-2):131-137
Jeong HG; Lee SS Suppressive effects of alpha-Hederin on 2,3,7,8- tetrachlorodibenzo-p-dioxin-mediated murine Cypla-1 expression in the mouse hepatoma Hepa-1c1c7 cells | 2 | 0
|
| 11563 | 13 | 11563 1999 CANCER LETTERS 143(2):199-204
Gonzalez FJ; Kimura S Role of gene knockout mice in understanding the mechanisms of chemical toxicity and carcinogenesis | 13 | 3
|
| 11564 | 7 | 11564 1999 CARCINOGENESIS 20(9):1825-1830
Kimura S; Kawabe M; Ward JM; Morishima H; Kadlubar FF; Hammons GJ; Fernandez-Salguero P; Gonzalez FJ CYP1A2 is not the primary enzyme responsible for 4- aminobiphenyl-induced hepatocarcinogenesis in mice | 14 | 4
|
| 11565 | 1 | 11565 1999 CELL 97(2):161-163
Auwerx J; Baulieu E; Beato M; Becker-Andre M; Burbach PH; Camerino G; Chambon P; Cooney A; Dejean A; Dreyer C; Evans RM; Gannon F; Giguere V; Gronemeyer H; Gustafson JA; Laudet V; Lazar MA; Mangelsdorf DJ; Milbrandt J; Milgrom E; Moore DD; O'Malley B; Parker M; Parker K; Perlmann T; Pfahl M; Rosenfeld MG; Samuels H; Schutz G; Sladek FM; Stunnenberg HG; Spedding M; Thummel C; Tsai MJ; Umesono K; Vennstrom B; Wahli W; Weinberger C; Willson TM; Yamamoto K; Nucl Receptors Nomenclature Comm A unified nomenclature system for the nuclear receptor superfamily | 143 | 4
|
| 11566 | 15 | 11566 1999 CELLULAR AND MOLECULAR NEUROBIOLOGY 19(3):301-308
Baker GB Special issue: Drug metabolism and psychiatry: Part I of II - Preface | 0 | 0
|
| 11567 | 20 | 11567 1999 CELLULAR AND MOLECULAR NEUROBIOLOGY 19(3):309-323
Glue P; Clement RP Cytochrome P450 enzymes and drug metabolism - Basic concepts and methods of assessment | 6 | 3
|
| 11568 | 34 | 11568 1999 CELLULAR AND MOLECULAR NEUROBIOLOGY 19(3):325-354
Coutts RT; Urichuk LJ Polymorphic cytochromes P450 and drugs used in psychiatry | 25 | 3
|
| 11569 | 16 | 11569 1999 CELLULAR AND MOLECULAR NEUROBIOLOGY 19(4):491-510
Fang J; Gorrod JW Metabolism, pharmacogenetics, and metabolic drug-drug interactions of antipsychotic drugs | 13 | 0
|
| 11570 | 13 | 11570 1999 CELLULAR AND MOLECULAR NEUROBIOLOGY 19(4):533-552
Chouinard G; Lefko-Singh K; Teboul E Metabolism of anxiolytics and hypnotics: Benzodiazepines, buspirone, zoplicone, and zolpidem | 2 | 0
|
| 11571 | 5 | 11571 1999 CELLULAR RESPONSES TO STRESS (64):129-139
Wolf CR; Smith G; Smith AG; Brown K; Henderson CJ Adaptive responses to environmental chemicals | 0 | 0
|
| 11572 | 14 | 11572 1999 CHEMICAL RESEARCH IN TOXICOLOGY 12(4):317-322
Kent UM; Yanev S; Hollenberg PF Mechanism-based inactivation of cytochromes P450 2B1 and P450 2B6 by n-propylxanthate | 13 | 4
|
| 11573 | 15 | 11573 1999 CHEMICAL RESEARCH IN TOXICOLOGY 12(7):582-587
Moreno RL; Kent UM; Hodge K; Hollenberg PF Inactivation of cytochrome P450 2E1 by benzyl isothiocyanate | 12 | 3
|
| 11574 | 29 | 11574 1999 CHEMICKE LISTY 93(4):229-237
Stiborova M; Hudecek I; Hodek P; Frei E Cytochromes P450 and human health | 3 | 1
|
| 11575 | 10 | 11575 1999 CHEMICO-BIOLOGICAL INTERACTIONS 117(3):257-268
Tateishi T; Asoh M; Nakura H; Watanabe M; Tanaka M; Kumai T; Kobayashi S Carbamazepine induces multiple cytochrome P450 subfamilies in rats | 7 | 0
|
| 11576 | 8 | 11576 1999 CHEMICO-BIOLOGICAL INTERACTIONS 123(1):63-79
Nicolas JM; Whomsley R; Collart P; Roba J In vitro inhibition of human liver drug metabolizing enzymes by second generation antihistamines | 5 | 0
|
| 11577 | 10 | 11577 1999 CHEMISTRY & BIOLOGY 6(10):R269-R272
Roberts GCK The power of evolution: accessing the synthetic potential of P450s | 4 | 1
|
| 11578 | 5 | 11578 1999 CHEMISTRY & BIOLOGY 6(10):699-706
Joo H; Arisawa A; Lin ZL; Arnold FH A high-throughput digital imaging screen for the discovery and directed evolution of oxygenases | 27 | 3
|
| 11579 | 7 | 11579 1999 CHEMOSPHERE 38(4):853-863
Vitas M; Smith KE; Plavec J; Kesselmeier J; Pajic T; Ferlan A; Zigon D; Kelly SL; Komel R Induction of steroidal hydroxylase activity by plant defence compounds in the filamentous fungus Cochliobolus lunatus | 4 | 0
|
| 11580 | 11 | 11580 1999 CLINICAL CANCER RESEARCH 5(8):2192-2197
Reid JM; Kuffel MJ; Miller JK; Rios R; Ames MM Metabolic activation of dacarbazine by human cytochromes P450: The role of CYP1A1, CYP1A2, and CYP2E1 | 14 | 3
|
| 11581 | 2 | 11581 1999 CLINICAL CANCER RESEARCH 5(11):3379-3384
Terwogt JMM; Malingre MM; Beijnen JH; Huinink WWT; Rosing H; Koopman FJ; van Tellingen O; Swart M; Schellens JHM Coadministration of oral cyclosporin a enables oral therapy with paclitaxel | 30 | 4
|
| 11582 | 4 | 11582 1999 CLINICAL NUTRITION 18(2):93-101
Fontana L; Moreira E; Torres MI; Periago JL; De Medina FS; Gil A Effects of dietary polyunsaturated fatty acids and nucleotides on tissue fatty acid profiles of rats with carbon tetrachloride-induced liver damage | 2 | 0
|
| 11583 | 52 | 11583 1999 CLINICAL PHARMACOKINETICS 37(6):485-505
de Wildt SN; Kearns GL; Leeder JS; van den Anker JN Cytochrome P450 3A - Ontogeny and drug disposition | 56 | 0
|
| 11584 | 11 | 11584 1999 CLINICAL PHARMACOLOGY & THERAPEUTICS 65(4):369-376
Martinez C; Albet C; Agundez JAG; Herrero E; Carrillo JA; Marquez M; Benitez J; Ortiz JA Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H-2-receptor antagonists | 16 | 1
|
| 11585 | 6 | 11585 1999 CLINICAL PHARMACOLOGY & THERAPEUTICS 66(2):110-117
Hamaoka N; Oda Y; Hase I; Mizutani K; Nakamoto T; Ishizaki T; Asada A Propofol decreases the clearance of midazolam by inhibiting CYP3A4: An in vivo and in vitro study | 15 | 1
|
| 11586 | 2 | 11586 1999 CLINICAL TRANSPLANTATION 13(1):62-64
Tiao GM; Martin J; Weber FL; Cohen RM; Hanto DW Addisonian crisis in a liver transplant patient due to fluconazole withdrawal | 1 | 0
|
| 11587 | 10 | 11587 1999 COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY 124(1):89-100
Neunaber R; Achazi RK A novel, endogenous inhibitor of 7-ethoxyresorufin-O-deethylase activity isolated from liver cytosolic fractions of bream (Abramis brama L.) | 1 | 1
|
| 11588 | 8 | 11588 1999 COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-PHARMACOLOGY TOXICOLOGY & ENDOCRINOLOGY 122(2):205-210
Levine SL; Oris JT Noncompetitive mixed-type inhibition of rainbow trout CYP1A catalytic activity by clotrimazole | 2 | 1
|
| 11589 | 5 | 11589 1999 COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-PHARMACOLOGY TOXICOLOGY & ENDOCRINOLOGY 123(1):67-73
Stupans I; Kong S; Kirlich A; Murray M; Bailey EL; Jones BR; McKinnon RA Hepatic microsomal enzyme activity in the koala and tammar wallaby: high 17 beta-hydroxysteroid oxidoreductase activity in koala liver microsomes | 8 | 2
|
| 11590 | 8 | 11590 1999 COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-PHARMACOLOGY TOXICOLOGY & ENDOCRINOLOGY 124(3):301-307
Wanwimolruk S; Zhang H; Coville PF; Saville DJ; Davis LS In vitro hepatic metabolism of a CYP3A-mediated drug, quinine, in Adelie penguins | 1 | 0
|
| 11591 | 5 | 11591 1999 CRITICAL CARE CLINICS 15(2):297-+
Weaver LK Carbon monoxide poisoning | 12 | 1
|
| 11592 | 30 | 11592 1999 CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES 36(4):329-363
Stratakis CA; Rennert OM Congenital adrenal hyperplasia: Molecular genetics and alternative approaches to treatment | 8 | 1
|
| 11593 | 53 | 11593 1999 CRITICAL REVIEWS IN TOXICOLOGY 29(1):59-124
Wormhoudt LW; Commandeur JNM; Vermeulen NPE Genetic polymorphisms of human N-acetyltransferase, cytochrome P450, glutathione-S-Transferase, and epoxide hydrolase enzymes: Relevance to xenobiotic metabolism and toxicity | 91 | 8
|
| 11594 | 6 | 11594 1999 CURRENT OPINION IN CHEMICAL BIOLOGY 3(1):22-27
Holland HL C-H activation | 8 | 0
|
| 11595 | 18 | 11595 1999 CURRENT PHARMACEUTICAL DESIGN 5(3):163-180
Njar VCO; Brodie AMH Inhibitors of 17 alpha-hydroxylase/17,20-lyase (CYP17): Potential agents for the treatment of prostate cancer | 19 | 2
|
| 11596 | 1 | 11596 1999 CYTOGENETICS AND CELL GENETICS 86(2):162-164
Wain H; White J; Povey S The changing challenges of nomenclature | 1 | 0
|
| 11597 | 1 | 11597 1999 DIABETES 48(9):1890-1895
Chung WK; Luke A; Cooper RS; Rotini C; Vidal-Puig A; Rosenbaum M; Chua M; Solanes G; Zheng M; Zhao L; LeDuc C; Eisberg A; Chu F; Murphy E; Schreier M; Aronne L; Caprio S; Kahle B; Gordon D; Leal SM; Goldsmith R; Andreu AL; Bruno C; DiMauro S; Heo MS; Lowe WL; Lowell BB; Allison DB; Leibel RL Genetic and physiologic analysis of the role of uncoupling protein 3 in human energy homeostasis | 26 | 0
|
| 11598 | 2 | 11598 1999 DIABETES 48(12):2437-2445
Shinozaki K; Kashiwagi A; Nishio Y; Okamura T; Yoshida Y; Masada M; Toda N; Kikkawa R Abnormal biopterin metabolism is a major cause of impaired endothelium-dependent relaxation through nitric oxide/O-2(-) imbalance in insulin-resistant rat aorta | 60 | 1
|
| 11599 | 13 | 11599 1999 DNA AND CELL BIOLOGY 18(9):723-730
Kikuta Y; Miyauchi Y; Kusunose E; Kusunose M Expression and molecular cloning of human liver leukotriene B-4 omega-hydroxylase (CYP4F2) gene | 17 | 7
|
| 11600 | 5 | 11600 1999 DRUG DEVELOPMENT RESEARCH 46(2):112-125
Dimmock JR; Puthucode RN; Tuchek J; Baker GB; Hinko CN; Steinmiller CL; Stables JP Anticonvulsant activities of 4-(4 '-fluorophenoxy) benzaldehyde semicarbazone | 1 | 0
|
| # | Cited nodes | Nodes / Authors | GCS | LCS |
| 11601 | 6 | 11601 1999 DRUG METABOLISM AND DISPOSITION 27(1):98-101
Huang JD; Guo WC; Lai MD; Guo YL; Lambert GH Detection of a novel cytochrome P-450 1A2 polymorphism (F21L) in Chinese | 18 | 3
|
| 11602 | 9 | 11602 1999 DRUG METABOLISM AND DISPOSITION 27(1):102-109
Yang TJ; Krausz KW; Sai Y; Gonzalez FJ; Gelboin HV Eight inhibitory monoclonal antibodies define the role of individual P-450S in human liver microsomal diazepam, 7- ethoxycoumarin, and imipramine metabolism | 18 | 9
|
| 11603 | 6 | 11603 1999 DRUG METABOLISM AND DISPOSITION 27(2):193-200
Singleton DW; Lei XD; Webb SJ; Prough RA; Geoghegan TE Cytochrome P-450 mRNAs are modulated by dehydroepiandrosterone, nafenopin, and triiodothyronine | 6 | 4
|
| 11604 | 7 | 11604 1999 DRUG METABOLISM AND DISPOSITION 27(2):250-254
Nicolas JM; Collart P; Gerin B; Mather G; Trager W; Levy R; Roba J In vitro evaluation of potential drug interactions with levetiracetam, a new antiepileptic agent | 26 | 2
|
| 11605 | 16 | 11605 1999 DRUG METABOLISM AND DISPOSITION 27(2):288-296
Bourrie M; Meunier V; Berger Y; Fabre G Role of cytochrome P-4502C9 in irbesartan oxidation by human liver microsomes | 22 | 1
|
| 11606 | 7 | 11606 1999 DRUG METABOLISM AND DISPOSITION 27(4):533-541
Granvil CP; Madan A; Sharkawi M; Parkinson A; Wainer IW Role of CYP2B6 and CYP3A4 in the in vitro N-dechloroethylation of (R)- and (S)-ifosfamide in human liver microsomes | 22 | 4
|
| 11607 | 18 | 11607 1999 DRUG METABOLISM AND DISPOSITION 27(4):542-548
Cummings BS; Zangar RC; Novak RF; Lash LH Cellular distribution of cytochromes P-450 in the rat kidney | 11 | 3
|
| 11608 | 9 | 11608 1999 DRUG METABOLISM AND DISPOSITION 27(5):600-604
Yanev S; Kent UM; Pandova B; Hollenberg PF Selective mechanism-based inactivation of cytochromes P-450 2B1 and P-450 2B6 by a series of xanthates | 13 | 3
|
| 11609 | 16 | 11609 1999 DRUG METABOLISM AND DISPOSITION 27(7):792-797
Nakajima M; Ohyama K; Nakamura S; Shimada N; Yamazaki H; Yokoi T Inhibitory effects of azelastine and its metabolites on drug oxidation catalyzed by human cytochrome P-450 enzymes | 9 | 4
|
| 11610 | 5 | 11610 1999 DRUG METABOLISM AND DISPOSITION 27(7):804-809
Zhang QY; Dunbar D; Ostrowska A; Zeisloft S; Yang J; Kaminsky LS Characterization of human small intestinal cytochromes P-450 | 41 | 10
|
| 11611 | 7 | 11611 1999 DRUG METABOLISM AND DISPOSITION 27(8):860-865
Kobayashi K; Nakajima M; Oshima K; Shimada N; Yokoi T; Chiba K Involvement of CYP2E1 as a low-affinity enzyme in phenacetin O- deethylation in human liver microsomes | 10 | 3
|
| 11612 | 21 | 11612 1999 DRUG METABOLISM AND DISPOSITION 27(9):999-1004
Yamazaki H; Nakajima M; Nakamura M; Asahi S; Shimada N; Gillam EMJ; Guengerich FP; Shimada T; Yokoi T Enhancement of cytochrome P-450 3A4 catalytic activities by cytochrome b(5) in bacterial membranes | 19 | 11
|
| 11613 | 26 | 11613 1999 DRUG METABOLISM AND DISPOSITION 27(9):1017-1023
McGinnity DF; Griffin SJ; Moody GC; Voice M; Hanlon S; Friedberg T; Riley RJ Rapid characterization of the major drug-metabolizing human hepatic cytochrome P-450 enzymes expressed in Escherichia coli | 16 | 2
|
| 11614 | 9 | 11614 1999 DRUG METABOLISM AND DISPOSITION 27(9):1068-1073
Becquemont L; Mouajjah S; Escaffre O; Beaune P; Funck-Brentano C; Jaillon P Cytochrome P-450 3A4 and 2C8 are involved in zopiclone metabolism | 9 | 3
|
| 11615 | 16 | 11615 1999 DRUG METABOLISM AND DISPOSITION 27(10):1117-1122
Masimirembwa CM; Otter C; Berg M; Jonsson M; Leidvik B; Jonsson E; Johansson T; Backman A; Edlund A; Andersson TB Heterologous expression and kinetic characterization of human cytochromes P-450: Validation of a pharmaceutical tool for drug metabolism research | 23 | 2
|
| 11616 | 15 | 11616 1999 DRUG METABOLISM AND DISPOSITION 27(12):1381-1391
Nakajima M; Nakamura S; Tokudome S; Shimada N; Yamazaki H; Yokoi T Azelastine N-demethylation by cytochrome P-450 (CYP) 3A4, CYP2D6, and CYP1A2 in human liver microsomes: Evaluation of approach to predict the contribution of multiple CYPS | 19 | 4
|
| 11617 | 11 | 11617 1999 DRUG METABOLISM AND DISPOSITION 27(12):1429-1433
Kobayashi K; Abe S; Nakajima M; Shimada N; Tani M; Chiba K; Yamamoto T Role of human CYP2B6 in S-mephobarbital N-demethylation | 9 | 3
|
| 11618 | 12 | 11618 1999 DRUG METABOLISM AND DISPOSITION 27(12):1512-1518
Hosagrahara VP; Hansen LK; Remmel RP Induction of the metabolism of midazolam by rifampin in cultured porcine hepatocytes: Preliminary evidence for CYP3A isoforms in pigs | 5 | 1
|
| 11619 | 3 | 11619 1999 DRUG METABOLISM REVIEWS 31(1):15-28
Wrighton SA; Ring BJ Predicting drug interactions and pharmacokinetic variability with in vitro methods: The olanzapine experience | 10 | 2
|
| 11620 | 21 | 11620 1999 DRUG METABOLISM REVIEWS 31(1):159-174
Porter TD; Chang SY Strategies to enhance the coexpression of cytochrome P450 2E1 and reductase in bacteria | 3 | 3
|
| 11621 | 13 | 11621 1999 DRUG METABOLISM REVIEWS 31(1):195-203
Jenkins CM; Waterman MR Flavodoxin as a model for the P450-interacting domain of NADPH cytochrome P450 reductase | 0 | 0
|
| 11622 | 49 | 11622 1999 DRUG METABOLISM REVIEWS 31(1):205-234
Scarborough PE; Ma JX; Qu W; Zeldin DC P450 subfamily CYP2J and their role in the bioactivation of arachidonic acid in extrahepatic tissues | 23 | 11
|
| 11623 | 0 | 11623 1999 DRUG METABOLISM REVIEWS 31(2):297-302
Estabrook RW A tribute to Alfred Goerge Hildebrandt | 0 | 0
|
| 11624 | 22 | 11624 1999 DRUG METABOLISM REVIEWS 31(2):317-331
Estabrook RW Discovering the functions of cytochrome P450 in drug metabolism: The role of Alfred Hildebrandt | 0 | 0
|
| 11625 | 11 | 11625 1999 DRUG METABOLISM REVIEWS 31(2):333-342
Kagawa N; Bischof LJ; Cheng PY; Anwar A; Waterman MR Biochemical diversity of peptide-hormone-dependent regulation of steroidogenic P450s | 3 | 0
|
| 11626 | 37 | 11626 1999 DRUG METABOLISM REVIEWS 31(2):351-364
Schenkman JB; Jansson I Interactions between cytochrome P450 and cytochrome b(5) | 17 | 8
|
| 11627 | 16 | 11627 1999 DRUG METABOLISM REVIEWS 31(2):503-522
Waxman DJ; Chen L; Hecht JED; Jounaidi Y Cytochrome P450-based cancer gene therapy: Recent advances and future prospects | 24 | 1
|
| 11628 | 23 | 11628 1999 DRUG METABOLISM REVIEWS 31(2):523-544
Friedberg T; Pritchard MP; Bandera M; Hanlon SP; Yao D; McLaughlin LA; Ding S; Burchell B; Wolf CR Merits and limitations of recombinant models for the study of human P450-mediated drug metabolism and toxicity: An intralaboratory comparison | 15 | 3
|
| 11629 | 75 | 11629 1999 DRUG METABOLISM REVIEWS 31(3):719-754
Ekins S; Wrighton SA The role of CYP2B6 in human xenobiotic metabolism | 36 | 8
|
| 11630 | 7 | 11630 1999 DRUG METABOLISM REVIEWS 31(4):971-997
Baliga R; Ueda N; Walker PD; Shah SV Oxidant mechanisms in toxic acute renal failure | 36 | 1
|
| 11631 | 8 | 11631 1999 DRUGS 58(2):233-255
Njar VCO; Brodie AMH Comprehensive pharmacology and clinical efficacy of aromatase inhibitors | 18 | 0
|
| 11632 | 5 | 11632 1999 DRUGS & AGING 14(2):75-90
Patterson A; Harris AL Molecular chemotherapy for breast cancer | 13 | 0
|
| 11633 | 7 | 11633 1999 ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY 43(1):74-82
van Dam RA; Ahokas JT; Holdway DA Chronic toxicity of diethylenetriamine pentaacetic acid to crimson-spotted rainbowfish (Melanotaenia fluviatilis): Effects on reproduction, condition, and ethoxyresorufin O-deethylase activity | 1 | 0
|
| 11634 | 13 | 11634 1999 ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY 43(3):252-260
Scholz S; Segner H Induction of CYP1A in primary cultures of rainbow trout (Oncorhynchus mykiss) liver cells: Concentration-response relationships of four model substances | 11 | 1
|
| 11635 | 8 | 11635 1999 ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY 44(1):118-128
Bols NC; Schirmer K; Joyce EM; Dixon DG; Greenberg BM; Whyte JJ Ability of polycyclic aromatic hydrocarbons to induce 7- ethoxyresorufin-o-deethylase activity in a trout liver cell line | 27 | 1
|
| 11636 | 1 | 11636 1999 ENDOCRINOLOGY 140(10):4732-4738
Teixeira J; Fynn-Thompson E; Payne AH; Donahoe PK Mullerian-inhibiting substance regulates androgen synthesis at the transcriptional level | 28 | 0
|
| 11637 | 16 | 11637 1999 ENDOCRINOLOGY 140(12):5609-5618
Hu MC; Chou SJ; Huang YY; Hsu NC; Li H; Chung BC Tissue-specific, hormonal, and developmental regulation of SCC- LacZ expression in transgenic mice leads to adrenocortical zone characterization | 14 | 1
|
| 11638 | 12 | 11638 1999 ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA 28(2):265-+
Rosenfield RL Ovarian and adrenal function in polycystic ovary syndrome | 17 | 0
|
| 11639 | 23 | 11639 1999 ENVIRONMENTAL HEALTH PERSPECTIVES 107():37-47
Hirvonen A Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancer | 27 | 1
|
| 11640 | 6 | 11640 1999 ENVIRONMENTAL SCIENCE & TECHNOLOGY 33(10):1671-1674
Uchimura M; Sandeaux R; Larroque C The enzymatic detoxifying system of a native Mediterranean Scorpio fish is affected by Caulerpa taxifolia in its environment | 2 | 0
|
| 11641 | 10 | 11641 1999 ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY 18(11):2565-2573
Levine SL; Oris JT; Denison MS Modulation of CYP1A expression in rainbow trout by a technical grade formulation of propiconazole | 3 | 0
|
| 11642 | 4 | 11642 1999 ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY 7(2):95-107
Pinelli E; El Adlouni C; Pipy B; Quartulli F; Pfohl-Leszkowicz A Roles of cyclooxygenase and lipoxygenases in ochratoxin A genotoxicity in human epithelial lung cells | 6 | 0
|
| 11643 | 1 | 11643 1999 ENZYMOLOGY AND MOLECULAR BIOLOGY OF CARBONYL METABOLISM 7 463():255-263
Ziegler TL; Vasiliou V Aldehyde dehydrogenase gene superfamily - The 1998 update | 5 | 0
|
| 11644 | 3 | 11644 1999 ESSAYS IN BIOCHEMISTRY, VOL 34, 1999 34():71-83
Sligar SG Nature's universal oxygenases: the cytochromes P450 | 6 | 0
|
| 11645 | 5 | 11645 1999 EUROPEAN HEART JOURNAL SUPPLEMENTS 1(T):T7-T12
Horsmans Y Differential metabolism of statins: importance in drug-drug interactions | 5 | 0
|
| 11646 | 5 | 11646 1999 EUROPEAN HEART JOURNAL SUPPLEMENTS 1(T):T13-T18
Weissberg PL Atherosclerosis involves more than just lipids: plaque dynamics | 6 | 0
|
| 11647 | 1 | 11647 1999 EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY AND OCCUPATIONAL PHYSIOLOGY 80(1):22-27
Wang H; Hiatt WR; Barstow TJ; Brass EP Relationships between muscle mitochondrial DNA content, mitochondrial enzyme activity and oxidative capacity in man: alterations with disease | 15 | 1
|
| 11648 | 11 | 11648 1999 EUROPEAN JOURNAL OF BIOCHEMISTRY 259(3):731-738
Sakaki T; Sawada N; Takeyama KI; Kato S; Inouye K Enzymatic properties of mouse 25-hydroxyvitamin D-3 1 alpha- hydroxylase expressed in Escherichia coli | 13 | 3
|
| 11649 | 8 | 11649 1999 EUROPEAN JOURNAL OF BIOCHEMISTRY 260(2):347-354
Arnesano F; Banci L; Bertini I; Felli IC; Koulougliotis D Solution structure of the B form of oxidized rat microsomal cytochrome b(5) and backbone dynamics via N-15 rotating-frame NMR-relaxation measurements - Biological implications | 19 | 3
|
| 11650 | 7 | 11650 1999 EUROPEAN JOURNAL OF BIOCHEMISTRY 260(3):768-773
Kisselev P; Tuckey RC; Woods ST; Triantopoulos T; Schwarz D Enzymatic properties of vesicle-reconstituted human cytochrome P450SCC (CYP11A1) - Differences in functioning of the mitochondrial electron-transfer chain using human and bovine adrenodoxin and activation by cardiolipin | 2 | 0
|
| 11651 | 6 | 11651 1999 EUROPEAN JOURNAL OF BIOCHEMISTRY 262(1):43-48
Sakaki T; Sawada N; Nonaka Y; Ohyama Y; Inouye K Metabolic studies using recombinant Escherichia coli cells producing rat mitochondrial CYP24 - CYP24 can convert 1 alpha,25-dihydroxyvitamin D-3 to calcitroic acid | 16 | 3
|
| 11652 | 21 | 11652 1999 EUROPEAN JOURNAL OF BIOCHEMISTRY 262(2):435-446
Cabello-Hurtado F; Taton M; Forthoffer N; Kahn R; Bak S; Rahier A; Werck-Reichhart D Optimized expression and catalytic properties of a wheat obtusifoliol 14 alpha-demethylase (CYP51) expressed in yeast - Complementation of erg11 Delta yeast mutants by plant CYP51 | 8 | 0
|
| 11653 | 19 | 11653 1999 EUROPEAN JOURNAL OF BIOCHEMISTRY 264(1):19-26
Posti K; Leinonen S; Tetri S; Kottari S; Viitala P; Pelkonen O; Raunio H Modulation of murine phenobarbital-inducible CYP2A5, CYP2B10 and CYP1A enzymes by inhibitors of protein kinases and phosphatases | 4 | 1
|
| 11654 | 11 | 11654 1999 EUROPEAN JOURNAL OF BIOCHEMISTRY 265(3):950-956
Sawada N; Sakaki T; Kitanaka S; Takeyama K; Kato S; Inouye K Enzymatic properties of human 25-hydroxyvitamin D-3 1 alpha- hydroxylase - Coexpression with adrenodoxin and NADPH- adrenodoxin reductase in Escherichia coli | 14 | 3
|
| 11655 | 4 | 11655 1999 EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 55(5):341-347
Bonnabry P; Sievering J; Leemann T; Dayer P Quantitative drug interactions prediction system (Q-DIPS): a computer-based prediction and management support system for drug metabolism interactions | 6 | 1
|
| 11656 | 3 | 11656 1999 EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS 24(1):63-68
Klinger W; Oelschlager H; Rothley D; Karge E; Seeling A Interaction of chlormezanone enantiomers with rat liver microsomes | 1 | 0
|
| 11657 | 8 | 11657 1999 EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS 24(2):141-147
Zhang W; Parentau H; Greenly RL; Metz CA; Aggarwal S; Wainer IW; Tracy TS Effect of protein-calorie malnutrition on cytochromes P450 and glutathione S-transferase | 5 | 1
|
| 11658 | 14 | 11658 1999 EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS 24(3):243-248
Czekaj P; Nowaczyk-Dura G Inhibiting effect of ethinylestradiol/levonorgestrel combination on microsomal enzymatic activities in rat liver and kidney | 1 | 1
|
| 11659 | 7 | 11659 1999 EUROPEAN JOURNAL OF ENDOCRINOLOGY 141(1):35-39
Gallo M; Aragno M; Gatto V; Tamagno E; Brignardello E; Manti R; Danni O; Boccuzzi G Protective effect of dehydroepiandrosterone against lipid peroxidation in a human liver cell line | 4 | 0
|
| 11660 | 17 | 11660 1999 EUROPEAN NEUROPSYCHOPHARMACOLOGY 9(4):301-309
Prior TI; Chue PS; Tibbo P; Baker GB Drug metabolism and atypical antipsychotics | 24 | 2
|
| 11661 | 11 | 11661 1999 EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY 51(4-5):369-374
Lewis DFV Homology modelling of human cytochromes P450 involved in xenobiotic metabolism and rationalization of substrate selectivity | 11 | 2
|
| 11662 | 8 | 11662 1999 EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY 51(4-5):392-396
Meneguz A; Fortuna S; Lorenzini P; Volpe MT Influence of urethane and ketamine on rat hepatic cytochrome P450 in vivo | 2 | 0
|
| 11663 | 12 | 11663 1999 EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY 51(4-5):412-417
Raunio H; Hakkola J; Hukkanen J; Lassila A; Paivarinta K; Pelkonen O; Anttila S; Piipari R; Boobis A; Edwards RJ Expression of xenobiotic-metabolizing CYPs in human pulmonary tissue | 19 | 6
|
| 11664 | 5 | 11664 1999 EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY 51(4-5):455-457
Zviarynski IU; Zavodnik LB The effect of folic acid on the drug metabolizing liver function in man with viral hepatitis | 1 | 0
|
| 11665 | 4 | 11665 1999 EXPERIMENTAL CELL RESEARCH 250(2):284-297
Sonneveld E; van den Brink CE; van der Leede BJM; Maden M; van der Saag PT Embryonal carcinoma cell lines stably transfected with mRAR beta 2-lacZ: Sensitive system for measuring levels of active retinoids | 7 | 0
|
| 11666 | 0 | 11666 1999 FASEB JOURNAL 13(7):A1345-A1345
Guryev OL; Gilep A; Usanov SA; Estabrook RW Cytochrome P4503A4-cytochrome bs interactions: Biological relevance of heme transfer | 0 | 0
|
| 11667 | 1 | 11667 1999 FEBS LETTERS 456(1):85-88
Jornvall H Motifer, a search tool for finding amino acid sequence patterns from nucleotide sequence databases | 0 | 0
|
| 11668 | 8 | 11668 1999 FEBS LETTERS 458(2):97-102
Schroder G; Unterbusch E; Kaltenbach M; Schmidt J; Strack D; De Luca V; Schroder J Light-induced cytochrome P450-dependent enzyme in indole alkaloid biosynthesis: tabersonine 16-hydroxylase | 19 | 3
|
| 11669 | 5 | 11669 1999 FEBS LETTERS 460(2):309-314
Neve EPA; Ingelman-Sundberg M A soluble NH2-terminally truncated catalytically active form of rat cytochrome P450 2E1 targeted to liver mitochondria | 10 | 4
|
| 11670 | 13 | 11670 1999 FEBS LETTERS 462(3):283-288
Lamb DC; Kelly DE; Manning NJ; Kaderbhai MA; Kelly SL Biodiversity of the P450 catalytic cycle: yeast cytochrome b(5)/NADH cytochrome b(5) reductase complex efficiently drives the entire sterol 14-demethylation (CYP51) reaction | 12 | 5
|
| 11671 | 6 | 11671 1999 FERTILITY AND STERILITY 71(2):328-333
Nagamani M; Urban R Increased expression of messenger ribonucleic acid encoding cytochrome P450 cholesterol side-chain cleavage and P450 17 alpha-hydroxylase enzymes in ovarian hyperthecosis | 4 | 0
|
| 11672 | 4 | 11672 1999 FERTILITY AND STERILITY 71(3):528-535
Jose M; Puche C; Cabero A; Cabero L; Meseguer A Expression of P450c17 messenger ribonucleic acid in postmenopausal human ovary tissues | 5 | 0
|
| 11673 | 35 | 11673 1999 FOOD AND CHEMICAL TOXICOLOGY 37(4):423-453
Lake BG Coumarin metabolism, toxicity and carcinogenicity: Relevance for human risk assessment | 17 | 0
|
| 11674 | 6 | 11674 1999 FOOD AND CHEMICAL TOXICOLOGY 37(5):503-508
Ng HP; Wang YF; Lee CY; Hu ML Toxicological and antioxidant effects of short-term dehydroepiandrosterone injection in young rats fed diets deficient or adequate in vitamin E | 2 | 0
|
| 11675 | 17 | 11675 1999 FOOD AND CHEMICAL TOXICOLOGY 37(6):609-618
Renwick AB; Mistry H; Barton PT; Mallet F; Price RJ; Beamand JA; Lake BG Effect of some indole derivatives on xenobiotic metabolism and xenobiotic-induced toxicity in cultured rat liver slices | 9 | 2
|
| 11676 | 11 | 11676 1999 FREE RADICAL BIOLOGY AND MEDICINE 27(11-12):1267-1275
Nguyen NSD; Cottet-Maire F; Buetler TM; Lo Russo A; Krauskopf AS; Armstrong JM; Vickers AEM; Mace K; Ruegg UT Metabolism-dependent stimulation of reactive oxygen species and DNA synthesis by cyclosporin A in rat smooth muscle cells | 7 | 1
|
| 11677 | 13 | 11677 1999 GASTROENTEROLOGY CLINICS OF NORTH AMERICA 28(1):1-+
Vlahcevic ZR; Pandak WM; Stravitz RT Regulation of bile acid biosynthesis | 41 | 0
|
| 11678 | 4 | 11678 1999 GENE 226(2):327-338
Lundqvist E; Johansson I; Ingelman-Sundberg M Genetic mechanisms for duplication and multiduplication of the human CYP2D6 gene and methods for detection of duplicated CYP2D6 genes | 25 | 1
|
| 11679 | 9 | 11679 1999 GENERAL PHARMACOLOGY 33(4):325-336
Yang ZW; Zhang AM; Altura BT; Altura BM Hydrogen peroxide-induced endothelium-dependent relaxation of rat aorta - Involvement of Ca2+ and other cellular metabolites | 14 | 0
|
| 11680 | 1 | 11680 1999 GENETIC EPIDEMIOLOGY 17(4):253-273
Yang P; Schwartz AG; McAllister AE; Swanson GM; Aston CE Lung cancer risk in families of nonsmoking probands: Heterogeneity by age at diagnosis | 7 | 0
|
| 11681 | 4 | 11681 1999 GENOMICS 56(2):184-196
Gafvels M; Olin M; Chowdhary BP; Raudsepp T; Andersson U; Persson B; Jansson M; Bjorkhem I; Eggertsen G Structure and chromosomal assignment of the sterol 12 alpha- hydroxylase gene (CYP8B1) in human and mouse: Eukaryotic cytochrome P-450 gene devoid of introns | 15 | 2
|
| 11682 | 1 | 11682 1999 HEPATO-GASTROENTEROLOGY 46():1406-1408
Suematsu M Recent developments in hepatic circulatory physiology | 1 | 0
|
| 11683 | 11 | 11683 1999 HISTOLOGY AND HISTOPATHOLOGY 14(2):407-415
Sarasquete C; Munoz-Cueto JA; Ortiz JB; Rodriguez-Gomez FJ; Dinis MT; Segner H Immunocytochemical distribution of cytochrome P4501A (CYP1A) in developing gilthead seabream, Sparus aurata | 7 | 3
|
| 11684 | 15 | 11684 1999 HORMONE RESEARCH 51(5):211-222
Peter M; Dubuis JM; Sippell WG Disorders of the aldosterone synthase and steroid 11 beta- hydroxylase deficiencies | 6 | 0
|
| 11685 | 9 | 11685 1999 INDUSTRIAL HEALTH 37(4):440-448
Wang RS; Nakajima T; Honma T Different change patterns of the isozymes of cytochrome P450 and glutathione S-transferases in chemically induced liver damage in rat | 1 | 0
|
| 11686 | 10 | 11686 1999 INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY 29(2):145-151
Ranasinghe C; Hobbs AA Isolation and characterisation of a cytochrome b5 cDNA clone from Helicoverpa armigera (Hubner): possible involvement of cytochrome b5 in cytochrome P450 CYP6B7 activity towards pyrethroids | 1 | 0
|
| 11687 | 11 | 11687 1999 INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY 29(4):377-384
Crampton AL; Baxter GD; Barker SC Identification and characterisation of a cytochrome P450 gene and processed pseudogene from an arachnid: the cattle tick, Boophilus microplus | 3 | 3
|
| 11688 | 6 | 11688 1999 INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY 29(8):667-673
Lu KH; Bradfield JY; Keeley LL Juvenile hormone inhibition of gene expression for cytochrome P4504C1 in adult females of the cockroach, Blaberus discoidalis | 2 | 1
|
| 11689 | 45 | 11689 1999 INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY 29(9):757-777
Scott JG Cytochromes P450 and insecticide resistance | 30 | 6
|
| 11690 | 10 | 11690 1999 INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY 29(9):829-834
Crampton AL; Baxter CD; Barker SC A new family of cytochrome P450 genes (CYP41) from the cattle tick, Boophilus microplus | 0 | 0
|
| 11691 | 15 | 11691 1999 INSECT MOLECULAR BIOLOGY 8(2):149-159
Danielson PB; Foster JLM; Cooper SK; Fogleman JC Diversity of expressed cytochrome P450 genes in the adult Mediterranean Fruit Fly, Ceratitis capitata | 4 | 4
|
| 11692 | 6 | 11692 1999 INTERNATIONAL BIODETERIORATION & BIODEGRADATION 44(1):49-54
Gordeziani M; Khatisashvili G; Ananiashvili T; Varazashvili T; Kurashvili M; Kvesitadze G; Tkhelidze P Energetic significance of plant monooxygenase individual components participating in xenobiotics degradation | 3 | 0
|
| 11693 | 8 | 11693 1999 INTERNATIONAL JOURNAL OF ANDROLOGY 22(4):211-223
Carreau S; Genissel C; Bilinska B; Levallet J Sources of oestrogen in the testis and reproductive tract in the male | 41 | 0
|
| 11694 | 6 | 11694 1999 INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY 31(2):345-362
Arinc E; Cakir D Simultaneous purification and characterization of cytochrome b5 reductase and cytochrome b5 from sheep liver | 1 | 0
|
| 11695 | 1 | 11695 1999 INTERNATIONAL JOURNAL OF CANCER 83(5):679-684
Bhisey RA; Ramchandani AG; D'Souza AV; Borges AM; Notani PN Long-term carcinogenicity of pan masala in Swiss mice | 3 | 0
|
| 11696 | 2 | 11696 1999 INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY 21(7):455-462
Rezzani R; Rodella L; Bianchi R Early metabolic changes in peripheral blood cells of renal transplant recipients treated with Cyclosporine A | 1 | 0
|
| 11697 | 10 | 11697 1999 INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 3(1):33-39
Beurton F; Gueret G; Horisberger M; Cheron G; Cresteil T Transcriptional activation of CYP2C, MxA and Fas in sudden infant death syndrome | 8 | 2
|
| 11698 | 43 | 11698 1999 INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 3(3):227-238
Murray M Mechanisms and significance of inhibitory drug interactions involving cytochrome P450 enzymes (Review) | 11 | 3
|
| 11699 | 5 | 11699 1999 INTERNATIONAL JOURNAL OF RADIATION BIOLOGY 75(9):1189-1199
Yukawa O; Nakajima T; Yukawa M; Ozawa T; Yamada T Induction of radical scavenging ability and protection against radiation-induced damage to microsomal membranes following low- dose irradiation | 7 | 0
|
| 11700 | 9 | 11700 1999 JAPANESE JOURNAL OF APPLIED PHYSICS PART 1-REGULAR PAPERS SHORT NOTES & REVIEW PAPERS 38(1A):298-301
Suzuki-Tomii K; Ohta Y; Kawato S; Mitaku S Comparative experiments of protein denaturation for studying structural difference of homologous membrane proteins: P- 450(scc) and P-450(11 beta) | 0 | 0
|
| # | Cited nodes | Nodes / Authors | GCS | LCS |
| 11701 | 11 | 11701 1999 JCR-JOURNAL OF CLINICAL RHEUMATOLOGY 5(3):143-150
Feldweg AM; Leddy JP Drug interactions affecting the efficacy of corticosteroid therapy - A brief review with an illustrative case | 0 | 0
|
| 11702 | 9 | 11702 1999 JOURNAL OF APPLIED ICHTHYOLOGY-ZEITSCHRIFT FUR ANGEWANDTE ICHTHYOLOGIE 15(4-5):96-98
Agradi E; Brevini TAL; Bolla M; Baga R; Favetta LA Cytochrome P-450 levels and EROD activity in the Adriatic sturgeon (Acipenser naccarii, Chondrostei) and its induction by beta-Naphthoflavone | 1 | 0
|
| 11703 | 12 | 11703 1999 JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY 13(1):1-9
Sidhu JS; Omiecinski CJ Insulin-mediated modulation of cytochrome p450 gene induction profiles in primary rat hepatocyte cultures | 4 | 1
|
| 11704 | 13 | 11704 1999 JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY 13(2):77-82
Carr BA; Franklin MR Induction of drug metabolizing enzymes by 1,7-phenanthroline and oltipraz in mice is unrelated to Ah-responsiveness | 3 | 0
|
| 11705 | 7 | 11705 1999 JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY 13(6):307-315
Hu K; Bunce NJ Metabolism of polychlorinated dibenzo-p-dioxins by rat liver microsomes | 8 | 0
|
| 11706 | 7 | 11706 1999 JOURNAL OF BIOCHEMISTRY 125(6):1094-1103
Kobayashi M; Sakuradani E; Shimizu S Genetic analysis of cytochrome b(5) from arachidonic acid- producing fungus, Mortierella alpina 1S-4: Cloning, RNA editing and expression of the gene in Escherichia coli, and purification and characterization of the gene product | 8 | 0
|
| 11707 | 8 | 11707 1999 JOURNAL OF BIOCHEMISTRY 126(1):19-25
Ishida H; Kuruta Y; Gotoh O; Yamashita C; Yoshida Y; Noshiro M Structure, evolution, and liver-specific expression of sterol 12 alpha-hydroxylase P450 (CYP8B) | 8 | 3
|
| 11708 | 11 | 11708 1999 JOURNAL OF BIOCHEMISTRY 126(2):402-407
Nunoya K; Yokoi T; Takahashi Y; Kimura K; Kinoshita M; Kamataki T Homologous unequal cross-over within the human CYP2A gene cluster as a mechanism for the deletion of the entire CYP2A6 gene associated with the poor metabolizer phenotype | 26 | 4
|
| 11709 | 7 | 11709 1999 JOURNAL OF BIOCHEMISTRY 126(5):927-933
Nitahara Y; Aoyama Y; Horiuchi T; Noshiro M; Yoshida Y Purification and characterization of rat sterol 14-demethylase P450 (CYP51) expressed in Escherichia coli | 6 | 0
|
| 11710 | 11 | 11710 1999 JOURNAL OF BIOCHEMISTRY 126(6):1080-1089
Zimmer T; Ogura A; Ohta A; Takagi M Misfolded membrane-bound cytochrome P450 activates KAR2 induction through two distinct mechanisms | 2 | 0
|
| 11711 | 25 | 11711 1999 JOURNAL OF BIOCHEMISTRY AND MOLECULAR BIOLOGY 32(3):226-231
Moon JY; Bin Lim H; Sohn HO; Lee YG; Lee DW Acetone enhancement of cumene hydroperoxide-supported microsomal cytochrome P450-dependent benzo(a)pyrene hydroxylation | 1 | 0
|
| 11712 | 7 | 11712 1999 JOURNAL OF BIOCHEMISTRY AND MOLECULAR BIOLOGY 32(3):232-238
Kim KW; Kim HY; Park SS; Jeong HS; Park SH; Lee JY; Jeong JH; Moon YH Gender differences in activity and induction of hepatic microsomal cytochrome P-450 by 1-bromopropane in Sprague-Dawley rats | 1 | 0
|
| 11713 | 9 | 11713 1999 JOURNAL OF BIOLOGICAL CHEMISTRY 274(4):2045-2052
Pikuleva IA; Cao C; Waterman MR An additional electrostatic interaction between adrenodoxin and P450c27 (CYP27A1) results in tighter binding than between adrenodoxin and P450scc (CYP11A1) | 17 | 9
|
| 11714 | 11 | 11714 1999 JOURNAL OF BIOLOGICAL CHEMISTRY 274(8):4764-4769
Chen JK; Wang DW; Falck JR; Capdevila J; Harris RC Transfection of an active cytochrome P450 arachidonic acid epoxygenase indicates that 14,15-epoxyeicosatrienoic acid functions as an intracellular second messenger in response to epidermal growth factor | 37 | 13
|
| 11715 | 2 | 11715 1999 JOURNAL OF BIOLOGICAL CHEMISTRY 274(8):4985-4994
Houston M; Estevez A; Chumley P; Aslan M; Marklund S; Parks DA; Freeman BA Binding of xanthine oxidase to vascular endothelium - Kinetic characterization and oxidative impairment of nitric oxide- dependent signaling | 43 | 0
|
| 11716 | 9 | 11716 1999 JOURNAL OF BIOLOGICAL CHEMISTRY 274(11):7421-7430
Park SH; Liu XW; Hennighausen L; Davey HW; Waxman DJ Distinctive roles of STAT5a and STAT5b in sexual dimorphism of hepatic P450 gene expression - Impact of Stat5a gene disruption | 40 | 3
|
| 11717 | 4 | 11717 1999 JOURNAL OF BIOLOGICAL CHEMISTRY 274(14):9573-9580
Pou S; Keaton L; Surichamorn W; Rosen GM Mechanism of superoxide generation by neuronal nitric-oxide synthase | 46 | 3
|
| 11718 | 6 | 11718 1999 JOURNAL OF BIOLOGICAL CHEMISTRY 274(21):14545-14550
Mingot JM; Penalva MA; Fernandez-Canon JM Disruption of phacA, an Aspergillus nidulans gene encoding a novel cytochrome P450 monooxygenase catalyzing phenylacetate 2- hydroxylation, results in penicillin overproduction | 8 | 2
|
| 11719 | 47 | 11719 1999 JOURNAL OF BIOLOGICAL CHEMISTRY 274(25):17777-17788
Ma JX; Qu W; Scarborough PE; Tomer KB; Moomaw CR; Maronpot R; Davis LS; Breyer MD; Zeldin DC Molecular cloning, enzymatic characterization, developmental expression, and cellular localization of a mouse cytochrome p450 highly expressed in Kidney | 20 | 13
|
| 11720 | 7 | 11720 1999 JOURNAL OF BIOLOGICAL CHEMISTRY 274(45):32279-32286
Yamada K; Ogawa H; Honda S; Harada N; Okazaki T A GCM motif protein is involved in placenta-specific expression of human aromatase gene | 16 | 0
|
| 11721 | 18 | 11721 1999 JOURNAL OF BIOLOGICAL CHEMISTRY 274(51):36097-36106
Sevrioukova IF; Hazzard JT; Tollin G; Poulos TL The FMN to heme electron transfer in cytochrome P450BM-3 - Effect of chemical modification of cysteines engineered at the FMN-heme domain interaction site | 5 | 3
|
| 11722 | 4 | 11722 1999 JOURNAL OF CARDIOVASCULAR PHARMACOLOGY 33(1):12-18
Reilly MP; Moran N; Meagher E; Delanty N; Cucchiara AE; Lawson JA; Catella-Lawson F A randomized, placebo-controlled, crossover study of E5510 and aspirin in healthy volunteers | 1 | 0
|
| 11723 | 7 | 11723 1999 JOURNAL OF CELL SCIENCE 112(4):515-523
McLaughlin L; Burchell B; Pritchard M; Wolf CR; Friedberg T Treatment of mammalian cells with the endoplasmic reticulum- proliferator compactin strongly induces recombinant and endogenous xenobiotic metabolizing enzymes and 3-hydroxy-3- methylglutaryl-CoA reductase in vitro | 2 | 0
|
| 11724 | 4 | 11724 1999 JOURNAL OF CHEMICAL ECOLOGY 25(3):537-548
Rey D; Cuany A; Pautou MP; Meyran JC Differential sensitivity of mosquito taxa to vegetable tannins | 16 | 0
|
| 11725 | 1 | 11725 1999 JOURNAL OF CHEMICAL RESEARCH-S (1):32-33
Lerestif JM; Feuillet S; Bazureau JP; Hamelin J Novel synthesis of protected methyl 4-hydroxy-1,2,3,4- tetrahydroisoquinoline-3-carboxylate via cleavage of functionalized dihydrooxazoles (oxazolines) | 3 | 0
|
| 11726 | 8 | 11726 1999 JOURNAL OF CHROMATOGRAPHY A 848(1-2):149-159
Schwaneberg U; Sprauer A; Schmidt-Dannert C; Schmid RD P450 monooxygenase in biotechnology - I. Single-step, large- scale purification method for cytochrome P450BM-3 by anion- exchange chromatography | 10 | 8
|
| 11727 | 7 | 11727 1999 JOURNAL OF CHROMATOGRAPHY B 721(1):13-19
Yamazaki H; Tanaka M; Shimada T Highly sensitive high-performance liquid chromatographic assay for coumarin 7-hydroxylation and 7-ethoxycoumarin O- deethylation by human liver cytochrome P450 enzymes | 18 | 7
|
| 11728 | 7 | 11728 1999 JOURNAL OF CHROMATOGRAPHY B 734(1):23-29
Soucek P Novel sensitive high-performance liquid chromatographic method for assay of coumarin 7-hydroxylation | 2 | 0
|
| 11729 | 7 | 11729 1999 JOURNAL OF CHROMATOGRAPHY B 734(1):73-81
Testino SA; Ozarowski J; Thurston AW; Arrendale RF; Patonay G Determination of testosterone and 6 beta-hydroxytestosterone by gas chromatography-selected ion monitoring-mass spectrometry for the characterization of cytochrome p450 3A activity | 3 | 1
|
| 11730 | 2 | 11730 1999 JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 84(1):220-227
Feneberg R; Sparber M; Veldhuis JD; Mehls O; Ritz E; Schaefer F Synchronous fluctuations of blood insulin and lactate concentrations in humans | 1 | 0
|
| 11731 | 11 | 11731 1999 JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 84(9):3382-3385
Mapes S; Corbin CJ; Tarantal A; Conley A The primate adrenal zona reticularis is defined by expression of cytochrome b5, 17 alpha-hydroxylase/17,20-lyase cytochrome P450 (P450c17) and NADPH-cytochrome P450 reductase (reductase) but not 3 beta-hydroxysteroid dehydrogenase/Delta 5-4 isomerase (3 beta-HSD) | 14 | 4
|
| 11732 | 6 | 11732 1999 JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 84(11):4050-4054
Deladoey J; Fluck C; Bex M; Yoshimura N; Harada N; Mullis PE Aromatase deficiency caused by a novel P450(arom) gene mutation: Impact of absent estrogen production on serum gonadotropin concentration in a boy | 21 | 2
|
| 11733 | 25 | 11733 1999 JOURNAL OF CLINICAL INVESTIGATION 104(6):751-760
Holla VR; Makita K; Zaphiropoulos PG; Capdevila JH The kidney cytochrome P-4502C23 arachidonic acid epoxygenase is upregulated during dietary salt loading | 21 | 6
|
| 11734 | 10 | 11734 1999 JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS 24(2):87-92
Tanaka E Clinically significant pharmacokinetic drug interactions between antiepileptic drugs | 22 | 2
|
| 11735 | 9 | 11735 1999 JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS 24(5):323-329
Tanaka E Update: genetic polymorphism of drug metabolizing enzymes in humans | 19 | 5
|
| 11736 | 40 | 11736 1999 JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY 19(5):23S-35S
Greenblatt DJ; Von Moltke LL; Harmatz JS; Shader RI Human cytochromes and some newer antidepressants: Kinetics, metabolism, and drug interactions | 13 | 0
|
| 11737 | 13 | 11737 1999 JOURNAL OF ENZYME INHIBITION 14(3):175-+
Lewis DFV; Wiseman A; Tarbit MH Molecular modelling of lanosterol 14 alpha-demethylase (CYP51) from Saccharomyces cerevisiae via homology with CYP102, a unique bacterial cytochrome P450 isoform: Quantitative structure-activity relationships (QSARs) within two related series of antifungal azole derivatives | 9 | 1
|
| 11738 | 6 | 11738 1999 JOURNAL OF EXPERIMENTAL MARINE BIOLOGY AND ECOLOGY 233(2):285-300
Schroder HC; Batel R; Lauenroth S; Hassanein HMA; Lacorn M; Simat T; Steinhart H; Muller WEG Induction of DNA damage and expression of heat shock protein HSP70 by polychlorinated biphenyls in the marine sponge Suberites domuncula Olivi | 10 | 1
|
| 11739 | 7 | 11739 1999 JOURNAL OF HEPATOLOGY 30(6):1035-1044
Takemura S; Minamiyama Y; Imaoka S; Funae Y; Hirohashi K; Inoue M; Kinoshita H Hepatic cytochrome P450 is directly inactivated by nitric oxide, not by inflammatory cytokines, in the early phase of endotoxemia | 29 | 2
|
| 11740 | 11 | 11740 1999 JOURNAL OF HEPATOLOGY 31(2):263-270
Tanaka M; Nakura H; Tateishi T; Watanabe M; Nakaya S; Kumai T; Kobayashi S Ursodeoxycholic acid prevents hepatic cytochrome P450 isozyme reduction in rats with deoxycholic acid-induced liver injury | 4 | 0
|
| 11741 | 3 | 11741 1999 JOURNAL OF HEPATOLOGY 31(3):550-555
Krahenbuhl S; Kleinle S; Henz S; Leibundgut K; Liechti S; Zimmermann A; Wiesmann U Microvesicular steatosis, hemosiderosis and rapid development of liver cirrhosis in a patient with Pearson's syndrome | 7 | 0
|
| 11742 | 10 | 11742 1999 JOURNAL OF LABORATORY AND CLINICAL MEDICINE 134(2):133-140
Finnstrom N; Bjelfman C; Thorn M; Loof L; Rane A Quantitation of cytochrome P450 mRNAs in patients with suspected liver diseases as assessed by reverse transcriptase- polymerase chain reaction | 4 | 1
|
| 11743 | 25 | 11743 1999 JOURNAL OF LIPID RESEARCH 40(11):1990-1997
Adas F; Salaun JP; Berthou F; Picart D; Simon B; Amet Y Requirement for omega and (omega-1)-hydroxylations of fatty acids by human cytochromes P450 2E1 and 4A11 | 4 | 1
|
| 11744 | 4 | 11744 1999 JOURNAL OF LIPID RESEARCH 40(12):2195-2203
Wu ZL; Martin KO; Javitt NB; Chiang JYL Structure and functions of human oxysterol 7 alpha-hydroxylase cDNAs and gene CYP7B1 | 22 | 3
|
| 11745 | 16 | 11745 1999 JOURNAL OF MEDICINAL CHEMISTRY 42(9):1515-1524
de Groot MJ; Ackland MJ; Horne VA; Alex AA; Jones BC Novel approach to predicting P450-mediated drug metabolism: Development of a combined protein and pharmacophore model for CYP2D6 | 54 | 0
|
| 11746 | 16 | 11746 1999 JOURNAL OF MEDICINAL CHEMISTRY 42(20):4062-4070
de Groot MJ; Ackland MJ; Horne VA; Alex AA; Jones BC A novel approach to predicting P450 mediated drug metabolism. CYP2D6 catalyzed N-dealkylation reactions and qualitative metabolite predictions using a combined protein and pharmacophore model for CYP2D6 | 42 | 0
|
| 11747 | 16 | 11747 1999 JOURNAL OF MOLECULAR BIOLOGY 289(4):981-990
Ziegler GA; Vonrhein C; Hanukoglu I; Schulz GE The structure of adrenodoxin reductase of mitochondrial P450 systems: Electron transfer for steroid biosynthesis | 24 | 3
|
| 11748 | 15 | 11748 1999 JOURNAL OF NEUROENDOCRINOLOGY 11(8):597-604
Rosenbrock H; Hagemeyer CE; Singec I; Knoth R; Volk B Testosterone metabolism in rat brain is differentially enhanced by phenytoin-inducible cytochrome P450 isoforms | 10 | 4
|
| 11749 | 2 | 11749 1999 JOURNAL OF NEUROSCIENCE 19(24):10843-10855
de la Houssaye BA; Mikule K; Nikolic D; Pfenninger KH Thrombin-induced growth cone collapse: Involvement of phospholipase A(2) and eicosanoid generation | 6 | 0
|
| 11750 | 7 | 11750 1999 JOURNAL OF PATHOLOGY 188(2):197-200
Hutson JL; Wickramasinghe SN Expression of CYP2E1 by human monocyte-derived macrophages | 2 | 1
|
| 11751 | 19 | 11751 1999 JOURNAL OF PESTICIDE SCIENCE 24(2):197-203
Ohkawa H; Tsujii H; Shimoji M; Imajuku Y; Imaishi H Cytochrome P450 biodiversity and plant protection | 5 | 0
|
| 11752 | 11 | 11752 1999 JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 288(2):463-471
Zhuo XL; Gu J; Zhang QY; Spink DC; Kaminsky LS; Ding XX Biotransformation of coumarin by rodent and human cytochromes P-450: Metabolic basis of tissue-selective toxicity in olfactory mucosa of rats and mice | 18 | 5
|
| 11753 | 14 | 11753 1999 JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 288(3):928-937
Yu LJ; Drewes P; Gustafsson K; Brain EGC; Hecht JED; Waxman DJ In vivo modulation of alternative pathways of P-450-catalyzed cyclophosphamide metabolism: Impact on pharmacokinetics and antitumor activity | 20 | 1
|
| 11754 | 7 | 11754 1999 JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 289(2):641-648
Dowsley TF; Reid K; Petsikas D; Ulreich JB; Fisher RL; Forkert PG Cytochrome P-450-dependent bioactivation of 1,1 - dichloroethylene to a reactive epoxide in human lung and liver microsomes | 7 | 2
|
| 11755 | 18 | 11755 1999 JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 289(2):661-667
Li DN; Pritchard MP; Hanlon SP; Burchell B; Wolf CR; Friedberg T Competition between cytochrome P-450 isozymes for NADPH- cytochrome P-450 oxidoreductase affects drug metabolism | 8 | 2
|
| 11756 | 24 | 11756 1999 JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 289(3):1611-1619
Mastyugin V; Aversa E; Bonazzi A; Vafaes C; Mieyal P; Schwartzman ML Hypoxia-induced production of 12-hydroxyeicosanoids in the corneal epithelium: Involvement of a cytochrome P-4504B1 isoform | 12 | 6
|
| 11757 | 8 | 11757 1999 JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 290(3):1250-1257
Barclay TB; Peters JM; Sewer MB; Ferrari L; Gonzalez FJ; Morgan ET Modulation of cytochrome P-450 gene expression in endotoxemic mice is tissue specific and peroxisome proliferator-activated receptor-alpha dependent | 26 | 2
|
| 11758 | 14 | 11758 1999 JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 290(3):1270-1277
Galisteo M; Marc N; Fautrel A; Guillouzo A; Corcos L; Lagadic-Gossmann D Involvement of cyclic nucleotide- and calcium-regulated pathways in phenobarbital-induced cytochrome P-450 3A expression in mouse primary hepatocytes | 6 | 2
|
| 11759 | 20 | 11759 1999 JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 291(1):424-433
Ekins S; Bravi G; Wikel JH; Wrighton SA Three-dimensional-quantitative structure activity relationship analysis of cytochrome P-450 3A4 substrates | 38 | 3
|
| 11760 | 17 | 11760 1999 JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 291(2):749-759
Mei Q; Tang CY; Assang C; Lin Y; Slaughter D; Rodrigues AD; Baillie TA; Rushmore TH; Shou MG Role of a potent inhibitory monoclonal antibody to cytochrome P-450 3A4 in assessment of human drug metabolism | 23 | 4
|
| 11761 | 6 | 11761 1999 JOURNAL OF PHARMACY AND PHARMACOLOGY 51(10):1167-1174
Zhao XJ; Ishizaki T An in-vitro study on the metabolism of rokitamycin and possible interactions of the drug with rat liver microsomes | 0 | 0
|
| 11762 | 2 | 11762 1999 JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY 69(1-6):205-210
Brodie A; Lu Q; Long B Aromatase and its inhibitors | 14 | 0
|
| 11763 | 10 | 11763 1999 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 41(2):237-249
Gupta AK; Katz HI; Shear NH Drug interactions with itraconazole, fluconazole, and terbinafine and their management | 32 | 0
|
| 11764 | 4 | 11764 1999 JOURNAL OF THE AMERICAN OIL CHEMISTS SOCIETY 76(11):1283-1289
Vilker VL; Reipa V; Mayhew M; Holden MJ Challenges in capturing oxygenase activity in vitro | 5 | 2
|
| 11765 | 2 | 11765 1999 JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2 (2):297-300
Rosen GM; Pou S; Cohen MS; Hassett DJ; Britigan BE; Barber MJ; Cao GL; Cosby K; Sturgeon BE; Halpern HJ N-14-spin trapping of free radicals in the presence of N-15- spin labeled Neisseria gonorrhoeae | 0 | 0
|
| 11766 | 2 | 11766 1999 JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2 (8):1759-1763
Tsai P; Pou S; Straus R; Rosen GM Evaluation of various spin traps for the in vivo in situ detection of hydroxyl radical | 5 | 2
|
| 11767 | 3 | 11767 1999 JOURNAL OF THE NATIONAL CANCER INSTITUTE 91(3):215-225
Hursting SD; Slaga TJ; Fischer SM; DiGiovanni J; Phang JM Mechanism-based cancer prevention approaches: Targets, examples, and the use of transgenic mice | 36 | 0
|
| 11768 | 8 | 11768 1999 JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A 56(6):433-447
Nebbia C; Ceppa L; Dacasto M; Carletti M Triphenyltin acetate-mediated in vitro inactivation of rat liver cytochrome P-450 | 6 | 2
|
| 11769 | 23 | 11769 1999 JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS 2(2):183-210
Hu KK; Bunce NJ Metabolism of polychlorinated dibenzo-p-dioxins and related dioxin-like compounds | 14 | 0
|
| 11770 | 4 | 11770 1999 JOURNAL OF VOICE 13(3):424-446
Abitbol J; Abitbol P; Abitbol B Sex hormones and the female voice | 10 | 0
|
| 11771 | 2 | 11771 1999 LANGMUIR 15(20):6829-6836
Yeung C; Purves T; Kloss AA; Kuhl TL; Sligar S; Leckband D Cytochrome c recognition of immobilized, orientational variants of cytochrome b(5): Direct force and equilibrium binding measurements | 12 | 1
|
| 11772 | 11 | 11772 1999 LIFE SCIENCES 64(8):643-653
Starkel P; Sempoux C; Van den Berge V; Stevens M; De Saeger C; Desager JP; Horsmans Y CYP 3A proteins are expressed in human neutrophils and lymphocytes but are not induced by rifampicin | 11 | 3
|
| 11773 | 6 | 11773 1999 LIFE SCIENCES 64(10):827-835
Mesdjian E; Seree E; Charvet B; Mirrione A; Bourgarel-Rey V; Desobry A; Barra Y Metabolism of carbamazepine by CYP3A6: A model for in vitro drug interactions studies | 3 | 0
|
| 11774 | 6 | 11774 1999 LIFE SCIENCES 65(12):1257-1264
Jiang HB; Ichikawa Y Neuronal nitric oxide synthase catalyzes the reduction of 7- ethoxyresorufin | 4 | 0
|
| 11775 | 5 | 11775 1999 LIFE SCIENCES 65(17):1747-1756
Kitamura T; Tanaka K; Morita K; Saito S; Kiba T; Numata K; Sekihara H Dehydroepiandrosterone (DHEA) facilitates liver regeneration after partial hepatectomy in rats | 2 | 0
|
| 11776 | 10 | 11776 1999 MARINE BIOTECHNOLOGY 1(2):155-166
Carvan MJ; Ponomareva LV; Solis WA; Matlib RS; Puga A; Nebert DW Trout CYP1A3 gene: Recognition of fish DNA motifs by mouse regulatory proteins | 6 | 2
|
| 11777 | 9 | 11777 1999 MARINE BIOTECHNOLOGY 1(4):342-345
Ogino Y; Itakura T; Mitsuo R; Sato M Induction of two forms of eel cytochrome P450 1A genes by 3- methylcholanthrene | 2 | 1
|
| 11778 | 10 | 11778 1999 MARINE BIOTECHNOLOGY 1(4):353-358
Mitsuo R; Itakura T; Sato M Cloning and sequencing of cytochrome P450 1A complementary DNA in eel (Anguilla japonica) | 2 | 2
|
| 11779 | 10 | 11779 1999 MARINE BIOTECHNOLOGY 1(4):364-370
Ogino Y; Itakura T; Kato H; Aoki J; Sato M Functional analysis of promoter region from eel cytochrome P450 1A1 gene in transgenic medaka | 2 | 1
|
| 11780 | 10 | 11780 1999 MARINE BIOTECHNOLOGY 1(4):371-375
Aoki J; Itakura T; Kato H; Sato M Isolation and sequence analysis of the eel cytochrome P450 1A1 gene | 1 | 1
|
| 11781 | 3 | 11781 1999 MARINE ECOLOGY-PROGRESS SERIES 178():205-219
Muller WEG; Wiens M; Batel R; Steffen R; Schroder HC; Borojevic R; Custodio MR Establishment of a primary cell culture from a sponge: primmorphs from Suberites domuncula | 36 | 0
|
| 11782 | 2 | 11782 1999 MEDICAL SCIENCE RESEARCH 27(9):617-620
Kalapos MP Influence of acetone on the hepatotoxicity of methylglyoxal | 1 | 0
|
| 11783 | 10 | 11783 1999 MOLECULAR AND CELLULAR BIOCHEMISTRY 192(1-2):53-61
Engels W; van Bilsen M; Wolffenbuttel BHR; van der Vusse GJ; Glatz JFC Cytochrome P450, peroxisome proliferation, and cytoplasmic fatty acid binding protein content in liver, heart and kidney of the diabetic rat | 9 | 1
|
| 11784 | 16 | 11784 1999 MOLECULAR AND CELLULAR BIOCHEMISTRY 198(1-2):79-88
Ramana KV; Kohli KK Purification and characterization of the hepatic CYP2C and 3A isozymes from phenobarbitone pretreated rhesus monkey | 1 | 0
|
| 11785 | 11 | 11785 1999 MOLECULAR AND CELLULAR BIOCHEMISTRY 198(1-2):89-100
Ikegwuonu FI; Jefcoate CR Evidence for the involvement of the fatty acid and peroxisomal beta-oxidation pathways in the inhibition by dehydroepiandrosterone (DHEA) and induction by 2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD) and benz(a) anthracene (BA) of cytochrome P4501B1 (CYP1B1) in mouse embryo fibroblasts (C3H10T1/2 cells) | 5 | 0
|
| 11786 | 9 | 11786 1999 MOLECULAR AND CELLULAR BIOCHEMISTRY 200(1-2):169-176
Dhawan A; Parmar D; Dayal M; Seth PK Cytochrome P450 (P450) isoenzyme specific dealkylation of alkoxyresorufins in rat brain microsomes | 7 | 0
|
| 11787 | 9 | 11787 1999 MOLECULAR AND CELLULAR ENDOCRINOLOGY 153(1-2):183-196
Liu Z; Simpson ER Molecular mechanism for cooperation between Sp1 and steroidogenic factor-1 (SF-1) to regulate bovine CYP11A gene expression | 18 | 1
|
| 11788 | 11 | 11788 1999 MOLECULAR BIOLOGY 33(4):618-621
Matushkin YG; Morozova IN; Morozov PS Theoretical analysis of mutation spectra of cytochrome P450 | 0 | 0
|
| 11789 | 11 | 11789 1999 MOLECULAR DIAGNOSIS 4(4):365-379
Linder MW; Valdes R Pharmacogenetics in the practice of laboratory medicine | 9 | 0
|
| 11790 | 16 | 11790 1999 MOLECULAR ENDOCRINOLOGY 13(1):167-175
Geller DH; Auchus RJ; Miller WL P450c17 mutations R347H and R358Q selectively disrupt 17,20- lyase activity by disrupting interactions with P450 oxidoreductase and cytochrome b(5) | 33 | 8
|
| 11791 | 7 | 11791 1999 MOLECULAR ENDOCRINOLOGY 13(6):946-957
Nelson VL; Legro RS; Strauss JF; McAllister JM Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries | 34 | 1
|
| 11792 | 30 | 11792 1999 MOLECULAR ENDOCRINOLOGY 13(7):1169-1182
Auchus RJ; Miller WL Molecular modeling of human P450c17 (17 alpha- hydroxylase/17,20-lyase): Insights into reaction mechanisms and effects of mutations | 35 | 10
|
| 11793 | 14 | 11793 1999 MOLECULAR PHARMACOLOGY 55(2):279-287
Kurose K; Tohkin M; Fukuhara M A novel positive regulatory element that enhances hamster CYP2A8 gene expression mediated by xenobiotic responsive element | 4 | 2
|
| 11794 | 13 | 11794 1999 MOLECULAR PHARMACOLOGY 56(3):588-597
Schlezinger JJ; White RD; Stegeman JJ Oxidative inactivation of cytochrome P-450 1A (CYP1A) stimulated by 3,3 ',4,4 '-tetrachlorobiphenyl: Production of reactive oxygen by vertebrate CYP1As | 51 | 7
|
| 11795 | 10 | 11795 1999 MOLECULAR PHARMACOLOGY 56(6):1329-1339
Goodwin B; Hodgson E; Liddle C The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module | 97 | 27
|
| 11796 | 7 | 11796 1999 MOLECULAR PLANT-MICROBE INTERACTIONS 12(12):1044-1052
Oh BJ; Ko MK; Kim YS; Kim KS; Kostenyuk I; Kee HK A cytochrome P450 gene is differentially expressed in compatible and incompatible interactions between pepper (Capsicum annuum) and the anthracnose fungus, Colletotrichum gloeosporioides | 3 | 0
|
| 11797 | 16 | 11797 1999 MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS 428(1-2):115-124
Guengerich FP; Parikh A; Turesky RJ; Josephy PD Inter-individual differences in the metabolism of environmental toxicants: cytochrome P450 1A2 as a prototype | 9 | 4
|
| 11798 | 13 | 11798 1999 MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS 439(2):287-300
Kranendonk M; Fisher CW; Roda R; Carreira F; Theisen P; Laires A; Rueff J; Vermeulen NPE; Estabrook RW Escherichia coli MTC, a NADPH cytochrome P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450: Comparison of three types of expression systems | 6 | 6
|
| 11799 | 8 | 11799 1999 MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS 440(1):91-100
Lake BG; Beamand JA; Tredger JM; Barton PT; Renwick AB; Price RJ Inhibition of xenobiotic-induced genotoxicity in cultured precision-cut human and rat liver slices | 10 | 1
|
| 11800 | 26 | 11800 1999 MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS 441(1):73-83
Kranendonk M; Carreira F; Theisen P; Laires A; Fisher CW; Rueff J; Estabrook RW; Vermeulen NPE Escherichia coli MTC, a human NADPH P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450 isoforms 1A1, 1A2, 2A6, 3A4, or 3A5: catalytic activities and mutagenicity studies | 9 | 9
|
| # | Cited nodes | Nodes / Authors | GCS | LCS |
| 11801 | 12 | 11801 1999 MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS 442(2):113-120
Aryal P; Yoshikawa K; Terashita T; Guengerich FP; Shimada T; Oda Y Development of a new genotoxicity test system with Salmonella typhimurium OY1001/1A2 expressing human CYP1A2 and NADPH-P450 reductase | 11 | 7
|
| 11802 | 5 | 11802 1999 MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS 443(1-2):235-249
Hursting SD; Kari FW The anti-carcinogenic effects of dietary restriction: mechanisms and future directions | 15 | 1
|
| 11803 | 9 | 11803 1999 MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH 436(3):227-261
Taningher M; Malacarne D; Izzotti A; Ugolini D; Parodi S Drug metabolism polymorphisms as modulators of cancer susceptibility | 40 | 2
|
| 11804 | 4 | 11804 1999 MYCOLOGICAL RESEARCH 103():1009-1018
Gramss G; Kirsche B; Voigt KD; Gunther T; Fritsche W Conversion rates of five polycyclic aromatic hydrocarbons in liquid cultures of fifty-eight fungi and the concomitant production of oxidative enzymes | 11 | 0
|
| 11805 | 7 | 11805 1999 NATURE 399(6737):670-673
Joo H; Lin ZL; Arnold FH Laboratory evolution of peroxide-mediated cytochrome P450 hydroxylation | 99 | 20
|
| 11806 | 11 | 11806 1999 NEOPLASMA 46(6):363-367
Iscan M; Eke BC; Aygormez S; Coban T; Bulbul D 7-Ethoxyresorufin O-deethylase (EROD) activity is not capable of reflecting the overall malignant potential of breast cancer tissue | 0 | 0
|
| 11807 | 2 | 11807 1999 NEUROMUSCULAR DISORDERS 9(4):208-214
Weller B; Carpenter S; Lochmuller H; Karpati G Myopathy with trabecular muscle fibers | 3 | 0
|
| 11808 | 4 | 11808 1999 NEUROPHARMACOLOGY 38(7):979-989
Wu SN; Li HF; Jan CR; Shen AY Inhibition of Ca2+-activated K+ current by clotrimazole in rat anterior pituitary GH(3) cells | 18 | 1
|
| 11809 | 14 | 11809 1999 ONCOLOGY RESEARCH 11(11-12):523-528
Knupfer H; Knupfer MM; Hotfilder M; Preiss R P450-expression in brain tumors | 2 | 0
|
| 11810 | 5 | 11810 1999 ORAL ONCOLOGY 35(2):191-196
Tanimoto K; Hayashi S; Yoshiga K; Ichikawa T Polymorphisms of the CYP1A1 and GSTM1 gene involved in oral squamous cell carcinoma in association with a cigarette dose | 17 | 1
|
| 11811 | 7 | 11811 1999 PEDIATRIC RESEARCH 45(3):384-388
Dardis A; Saraco N; Rivarola MA; Belgorosky A Decrease in the expression of the 3 beta-hydroxysteroid dehydrogenase gene in human adrenal tissue during prepuberty and early puberty: Implications for the mechanism of adrenarche | 8 | 2
|
| 11812 | 5 | 11812 1999 PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY 64(1):33-46
Inui H; Ueyama Y; Shiota N; Okhawa Y; Ohkawa H Herbicide metabolism and cross-tolerance in transgenic potato plants expressing human CYP1A1 | 15 | 2
|
| 11813 | 5 | 11813 1999 PESTICIDE SCIENCE 55(11):1043-1058
Davies J; Caseley JC Herbicide safeners: a review | 11 | 0
|
| 11814 | 5 | 11814 1999 PHARMACEUTICAL RESEARCH 16(6):790-798
Kong ANT; Mandlekar S; Yu R; Lei W; Fasanmande A Pharmacodynamics and toxicodynamics of drug action: Signaling in cell survival and cell death | 9 | 1
|
| 11815 | 3 | 11815 1999 PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY 2(3):119-120
Crespi CL Assessing the potential for drug-drug interactions in an accelerated throughput mode | 6 | 0
|
| 11816 | 30 | 11816 1999 PHARMACOGENETICS 9(1):61-70
Louerat-Oriou B; Flinois JP; Beaune PH; Pompon D High yield purification and characterization of engineered human P450 1A2 and generation of immuno-inhibitor antibodies | 0 | 0
|
| 11817 | 7 | 11817 1999 PHARMACOGENETICS 9(2):131-144
Tantcheva-Poor I; Zaigler M; Rietbrock S; Fuhr U Estimation of cytochrome P-450CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test | 28 | 0
|
| 11818 | 9 | 11818 1999 PHARMACOGENETICS 9(2):239-250
Lovell DP; van Iersel M; Walters DG; Price RJ; Lake BG Genetic variation in the metabolism of coumarin in mouse liver | 3 | 0
|
| 11819 | 2 | 11819 1999 PHARMACOGENETICS 9(2):263-265
Sempoux C; Starkel P; Stevens M; Van Den Berge V; Horsmans Y Cytochrome P450 3A proteins are expressed in B lymphocytes but not in T lymphocytes | 9 | 3
|
| 11820 | 8 | 11820 1999 PHARMACOGENETICS 9(3):327-332
Chen GF; Tang YM; Green B; Lin DX; Guengerich FP; Daly AK; Caporaso NE; Kadlubar FF Low frequency of CYP2A6 gene polymorphism as revealed by a one- step polymerase chain reaction method | 27 | 3
|
| 11821 | 19 | 11821 1999 PHARMACOGENETICS 9(3):357-366
Schulz-Utermoehl T; Bennett AJ; Ellis SW; Tucker GT; Boobis AR; Edwards RJ Polymorphic debrisoquine 4-hydroxylase activity in the rat is due to differences in CYP2D2 expression | 11 | 0
|
| 11822 | 9 | 11822 1999 PHARMACOGENETICS 9(4):421-434
Vasiliou V; Bairoch A; Tipton KF; Nebert DW Eukaryotic aldehyde dehydrogenase (ALDH) genes: human polymorphisms, and recommended nomenclature based on divergent evolution and chromosomal mapping | 36 | 3
|
| 11823 | 14 | 11823 1999 PHARMACOLOGICAL REVIEWS 51(1):63-81
Mensah-Nyagan AG; Do-Rego JL; Beaujean D; Luu-The V; Pelletier G; Vaudry H Neurosteroids: Expression of steroidogenic enzymes and regulation of steroid biosynthesis in the central nervous system | 49 | 0
|
| 11824 | 20 | 11824 1999 PHARMACOLOGICAL REVIEWS 51(2):135-157
Lin JH; Chiba M; Baillie TA Is the role of the small intestine in first-pass metabolism overemphasized? | 50 | 4
|
| 11825 | 24 | 11825 1999 PHARMACOLOGY & THERAPEUTICS 84(2):121-131
Crespi CL; Miller VP The use of heterologously expressed drug metabolizing enzymes - state of the art and prospects for the future | 20 | 3
|
| 11826 | 10 | 11826 1999 PHARMACOLOGY & TOXICOLOGY 85(2):65-73
Eltom SE; Schwark WS CYP1A1 and CYP1B1, two hydrocarbon-inducible cytochromes P450, are constitutively expressed in neonate and adult goat liver, lung and kidney | 4 | 2
|
| 11827 | 9 | 11827 1999 PHYSIOLOGICAL AND MOLECULAR PLANT PATHOLOGY 55(6):317-326
Delserone LM; McCluskey K; Matthews DE; Vanetten HD Pisatin demethylation by fungal pathogens and nonpathogens of pea: association with pisatin tolerance and virulence | 8 | 2
|
| 11828 | 4 | 11828 1999 PHYTOCHEMISTRY 50(2):243-248
Bouwmeester HJ; Konings MCJM; Gershenzon J; Karp F; Croteau R Cytochrome P-450 dependent (+)-limonene-6-hydroxylation in fruits of caraway (Carum carvi) | 7 | 1
|
| 11829 | 5 | 11829 1999 PHYTOCHEMISTRY 52(7):1195-1202
Friederich S; Rueffer M; Asakawa Y; Zenk MH Cytochromes P-450 catalyze the formation of marchantins A and C in Marchantia polymorpha | 7 | 0
|
| 11830 | 7 | 11830 1999 PLANT AND CELL PHYSIOLOGY 40(11):1182-1186
Akashi T; Fukuchi-Mizutani M; Aoki T; Ueyama Y; Yonekura-Sakakibara K; Tanaka Y; Kusumi T; Ayabe S Molecular cloning and biochemical characterization of a novel cytochrome P450, flavone synthase II, that catalyzes direct conversion of flavanones to flavones | 12 | 1
|
| 11831 | 15 | 11831 1999 PLANT AND CELL PHYSIOLOGY 40(12):1232-1242
Takemoto D; Hayashi M; Doke N; Nishimura M; Kawakita K Molecular cloning of a defense-response-related cytochrome P450 gene from tobacco | 2 | 0
|
| 11832 | 10 | 11832 1999 PLANT JOURNAL 19(2):183-193
Kaltenbach M; Schroder G; Schmelzer E; Lutz V; Schroder J Flavonoid hydroxylase from Catharanthus roseus: cDNA, heterologous expression, enzyme properties and cell-type specific expression in plants | 13 | 2
|
| 11833 | 5 | 11833 1999 PLANT JOURNAL 19(4):441-451
Brugliera F; Barri-Rewell G; Holton TA; Mason JG Isolation and characterization of a flavonoid 3 '-hydroxylase cDNA clone corresponding to the Ht1 locus of Petunia hybrida | 24 | 0
|
| 11834 | 3 | 11834 1999 PLANT MOLECULAR BIOLOGY 40(2):237-248
Panavas T; Pikula A; Reid PD; Rubinstein B; Walker EL Identification of senescence-associated genes from daylily petals | 19 | 1
|
| 11835 | 4 | 11835 1999 PLANT MOLECULAR BIOLOGY REPORTER 17(4):355-361
Shimada Y; Ohbayashi M; Nakano-Shimada R; Okinaka Y; Kiyokawa S; Kikuchi Y A novel method to clone P450s with modified single-specific- primer PCR | 1 | 0
|
| 11836 | 6 | 11836 1999 PLANT PHYSIOLOGY 121(3):821-828
Akashi T; Aoki T; Ayabe S Cloning and functional expression of a cytochrome P450 cDNA encoding 2-hydroxyisoflavanone synthase involved in biosynthesis of the isoflavonoid skeleton in licorice | 27 | 2
|
| 11837 | 8 | 11837 1999 PLANT SCIENCE 149(2):105-113
Oudin A; Hamdi S; Ouelhazi L; Chenieux JC; Rideau M; Clastre M Induction of a novel cytochrome P450 (CYP96 family) in periwinkle (Catharanthus roseus) cells induced for terpenoid indole alkaloid production | 4 | 0
|
| 11838 | 3 | 11838 1999 POSTGRADUATE MEDICINE 105(2):193-+
Johnson MD; Newkirk G; White JR Clinically significant drug interactions - What you need to know before writing prescriptions | 15 | 4
|
| 11839 | 9 | 11839 1999 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 96(4):1750-1755
Siminszky B; Corbin FT; Ward ER; Fleischmann TJ; Dewey RE Expression of a soybean cytochrome P450 monooxygenase cDNA in yeast and tobacco enhances the metabolism of phenylurea herbicides | 19 | 6
|
| 11840 | 27 | 11840 1999 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 96(5):1863-1868
Sevrioukova IF; Li HY; Zhang H; Peterson JA; Poulos TL Structure of a cytochrome P450-redox partner electron-transfer complex | 73 | 23
|
| 11841 | 9 | 11841 1999 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 96(5):1977-1982
Buters JTM; Sakai S; Richter T; Pineau T; Alexander DL; Savas U; Doehmer J; Ward JM; Jefcoate CR; Gonzalez FJ Cytochrome P450 CYP1B1 determines susceptibility to 7,12- dimethylbenz[a]anthracene-induced lymphomas | 62 | 10
|
| 11842 | 3 | 11842 1999 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 96(13):7238-7243
Lund EG; Guileyardo JM; Russell DW cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain | 58 | 10
|
| 11843 | 3 | 11843 1999 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 96(22):12790-12797
New MI; Wilson RC Steroid disorders in children: Congenital adrenal hyperplasia and apparent mineralocorticoid excess | 20 | 0
|
| 11844 | 6 | 11844 1999 PROCEEDINGS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES 266(1414):1-12
von Schantz T; Bensch S; Grahn M; Hasselquist D; Wittzell H Good genes, oxidative stress and condition-dependent sexual signals | 48 | 0
|
| 11845 | 22 | 11845 1999 PROTEINS-STRUCTURE FUNCTION AND GENETICS 34(3):403-415
Chang YT; Loew GH Homology modeling and substrate binding study of human CYP4A11 enzyme | 19 | 8
|
| 11846 | 31 | 11846 1999 PROTEINS-STRUCTURE FUNCTION AND GENETICS 37(2):176-190
Payne VA; Chang YT; Loew GH Homology modeling and substrate binding study of human CYP2C9 enzyme | 17 | 3
|
| 11847 | 18 | 11847 1999 PROTEINS-STRUCTURE FUNCTION AND GENETICS 37(2):204-217
Payne VA; Chang YT; Loew GH Homology modeling and substrate binding study of human CYP2C18 and CYP2C19 enzymes | 5 | 0
|
| 11848 | 10 | 11848 1999 REVUE DES MALADIES RESPIRATOIRES 16(6BIS):1236-1243
Pairon JC; Housset B Biomarkers and exposure to asbestos. | 3 | 1
|
| 11849 | 2 | 11849 1999 RUSSIAN JOURNAL OF GENERAL CHEMISTRY 69(6):936-953
Shugalei IV; Tselinskii IV Nitroalkanes as initiators of radical chain processes in chemistry and biology | 1 | 0
|
| 11850 | 6 | 11850 1999 SCIENCE 285(5431):1276-1279
Node K; Huo YQ; Ruan XL; Yang BC; Spiecker M; Ley K; Zeldin DC; Liao JK Anti-inflammatory properties of cytochrome P450 epoxygenase- derived eicosanoids | 85 | 27
|
| 11851 | 1 | 11851 1999 SCIENCE 286(5447):2179-2184
White KP; Rifkin SA; Hurban P; Hogness DS Microarray analysis of Drosophila development during metamorphosis | 122 | 2
|
| 11852 | 2 | 11852 1999 SCIENCES DES ALIMENTS 19(5):515-542
Aurousseau B The origin of ovine carcass discoloration: a review. | 1 | 0
|
| 11853 | 9 | 11853 1999 STEROIDS 64(3):178-186
Holland HL Recent advances in applied and mechanistic aspects of the enzymatic hydroxylation of steroids by whole-cell biocatalysts | 8 | 1
|
| 11854 | 9 | 11854 1999 TOXICOLOGICAL SCIENCES 47(1):52-61
Korytko PJ; Casey AC; Bush B; Quimby FW Induction of hepatic cytochromes P450 in dogs exposed to a chronic low dose of polychlorinated biphenyls | 4 | 0
|
| 11855 | 13 | 11855 1999 TOXICOLOGICAL SCIENCES 48(2):151-156
Omiecinski CJ; Remmel RP; Hosagrahara VP Concise review of the cytochrome P450s and their roles in toxicology | 27 | 8
|
| 11856 | 2 | 11856 1999 TOXICOLOGICAL SCIENCES 49(1):15-28
Collins AS; Sumner SCJ; Borghoff SJ; Medinsky MA A physiological model for tert-amyl methyl ether and tert-amyl alcohol: Hypothesis testing of model structures | 7 | 0
|
| 11857 | 7 | 11857 1999 TOXICOLOGICAL SCIENCES 52(1):130-139
Inder RE; Bray BJ; Sipes IG; Rosengren RJ Role of cytochrome P4502E1 in retinol's attenuation of carbon tetrachloride-induced hepatotoxicity in the Swiss Webster mouse | 3 | 0
|
| 11858 | 27 | 11858 1999 TOXICOLOGY 133(1):1-33
Lewis DFV; Dickens M; Lake BG; Eddershaw PJ; Tarbit MH; Goldfarb PS Molecular modelling of the human cytochrome P450 isoform CYP2A6 and investigations of CYP2A substrate selectivity | 15 | 5
|
| 11859 | 38 | 11859 1999 TOXICOLOGY 139(1-2):53-79
Lewis DFV; Lake BG; George SG; Dickins M; Eddershaw PJ; Tarbit MH; Beresford AP; Goldfarb PS; Guengerich FP Molecular modelling of CYP1 family enzymes CYP1A1, CYP1A2, CYP1A6 and CYP1B1 based on sequence homology with CYP102 | 16 | 5
|
| 11860 | 0 | 11860 1999 TOXICOLOGY AND APPLIED PHARMACOLOGY 154(2):126-134
Metosh-Dickey CA; Mason RP; Winston GW Nitroarene reduction and generation of free radicals by cell- free extracts of wild-type, and nitroreductase-deficient and - enriched Salmonella typhimurium strains used in the umu gene induction assay | 1 | 0
|
| 11861 | 20 | 11861 1999 TOXICOLOGY AND APPLIED PHARMACOLOGY 155(1):96-106
Mahajan SS; Rifkind AB Transcriptional activation of avian CYP1A4 and CYP1A5 by 2,3,7,8-tetrachlorodibenzo-p-dioxin: Differences in gene expression and regulation compared to mammalian CYP1A1 and CYP1A2 | 10 | 4
|
| 11862 | 19 | 11862 1999 TOXICOLOGY AND APPLIED PHARMACOLOGY 156(3):231-240
Bhagwat SV; Mullick J; Raza H; Avadhani NG Constitutive and inducible cytochromes P450 in rat lung mitochondria: Xenobiotic induction, relative abundance, and catalytic properties | 10 | 1
|
| 11863 | 9 | 11863 1999 TOXICOLOGY AND APPLIED PHARMACOLOGY 157(3):157-165
Ertl RP; Bandiera SM; Buhler DR; Stegeman JJ; Winston GW Immunochemical analysis of liver microsomal cytochromes P450 of the American alligator, Alligator mississippiensis | 1 | 0
|
| 11864 | 14 | 11864 1999 TOXICOLOGY AND APPLIED PHARMACOLOGY 158(2):197-205
You L; Chan SK; Brace JM; Archibeque-Engle S; Casanova M; Corton JC; Heck HD Modulation of testosterone-metabolizing hepatic cytochrome P- 450 enzymes in developing Sprague-Dawley rats following in utero exposure to p,p '-DDE | 13 | 4
|
| 11865 | 5 | 11865 1999 TOXICOLOGY AND APPLIED PHARMACOLOGY 160(1):10-20
Letcher RJ; van Holsteijn I; Drenth HJ; Norstrom RJ; Bergman A; Safe S; Pieters R; van den Berg M Cytotoxicity and aromatase (CYP19) activity modulation by organochlorines in human placental JEG-3 and JAR choriocarcinoma cells | 12 | 1
|
| 11866 | 5 | 11866 1999 TOXICOLOGY IN VITRO 13(4-5):633-638
Bort R; Castell JV; Pfeifer A; Gomez-Lechon MJ; Mace K High expression of human CYP2C in immortalized human liver epithelial cells | 3 | 1
|
| 11867 | 36 | 11867 1999 TOXICOLOGY LETTERS 110(1-2):43-55
Adas F; Berthou F; Salaun JP; Dreano Y; Amet Y Interspecies variations in fatty acid hydroxylations involving cytochromes P450 2E1 and 4A | 6 | 3
|
| 11868 | 14 | 11868 1999 USPEKHI KHIMII 68(10):967-975
Shumyantseva VV; Bulko TV; Archakov AI Regulation of cytochrome P450S catalytic activities by means of physico-chemical methods | 0 | 0
|
| 11869 | 7 | 11869 1999 VETERINARY AND HUMAN TOXICOLOGY 41(4):210-212
Govindwar SP; Adav SS Effects of aflatoxin B-1 on the hepatic microsomal mixed function oxidase system during phenobarbital and benzo(a)pyrene treatment in chickens | 0 | 0
|
| 11870 | 14 | 11870 1999 VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY 434(5):401-411
Yokose T; Doy M; Taniguchi T; Shimada T; Kakiki M; Horie T; Matsuzaki Y; Mukai K Immunohistochemical study of cytochrome P4502C and 3A in human non-neoplastic and neoplastic tissues | 21 | 10
|
| 11871 | 6 | 11871 1999 VOPROSY MEDITSINSKOI KHIMII 45(1):30-36
Schwartz EI; Gulyaeva LF; Lyakhovich VV The interstrain differences in the enzymatic activity of CYP2B1 and expression of its gene in rat liver during induction with phenobarbital and triphenyldioxane | 0 | 0
|
| 11872 | 4 | 11872 1999 WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY 15(2):259-263
Salokhe MD; Govindwar SP Effect of carbon source on the biotransformation enzymes in Serratia marcescens | 0 | 0
|
| 11873 | 9 | 11873 1999 WORLD JOURNAL OF SURGERY 23(1):6-11
Izuishi K; Wakabayashi H; Kokudo Y; Maeba T; Ryu M; Maeta H Microsomal cytochrome P-450 monooxygenase system and its drug- metabolizing activity after partial portal vein ligation in the rat | 1 | 0
|
| 11874 | 12 | 11874 1999 XENOBIOTICA 29(3):217-229
Shiraga T; Kaneko H; Iwasaki K; Tozuka Z; Suzuki A; Hata T Identification of cytochrome P450 enzymes involved in the metabolism of zotepine, an antipsychotic drug, in human liver microsomes | 9 | 1
|
| 11875 | 25 | 11875 1999 XENOBIOTICA 29(3):231-241
Yamazaki H; Shimada T Effects of arachidonic acid, prostaglandins, retinol, retinoic acid and cholecalciferol on xenobiotic oxidations catalysed by human cytochrome P450 enzymes | 15 | 5
|
| 11876 | 19 | 11876 1999 XENOBIOTICA 29(3):269-279
Ogg MS; Williams JM; Tarbit M; Goldfarb PS; Gray TJB; Gibson GG A reporter gene assay to assess the molecular mechanisms of xenobiotic-dependent induction of the human CYP3A4 gene in vitro | 32 | 10
|
| 11877 | 54 | 11877 1999 XENOBIOTICA 29(4):361-393
Lewis DFV; Lake BG; Dickins M; Eddershaw PJ; Tarbit MH; Goldfarb PS Molecular modelling of CYP2B6, the human CYP2B isoform, by homology with the substrate-bound CYP102 crystal structure: evaluation of CYP2B6 substrate characteristics, the cytochrome b(5) binding site and comparisons with CYP2B1 and CYP2B4 | 26 | 10
|
| 11878 | 13 | 11878 1999 XENOBIOTICA 29(5):437-451
Chen GF; Ronis MJJ; Ingelman-Sundberg M; Badger TM Hormonal regulation of microsomal cytochrome P4502E1 and P450 reductase in rat liver and kidney | 16 | 2
|
| 11879 | 14 | 11879 1999 XENOBIOTICA 29(6):629-640
Roos PH Common multiple interactions of tricyclic antidepressants and orphenadrine with liver microsomal cytochrome P450 enzymes of the rat | 0 | 0
|
| 11880 | 2 | 11880 1999 XENOBIOTICA 29(7):655-691
Rockett JC; Esdaile DJ; Gibson GG Differential gene expression in drug metabolism and toxicology: practicalities, problems and potential | 4 | 0
|
| 11881 | 13 | 11881 1999 XENOBIOTICA 29(7):703-717
Grace JM; Skanchy DJ; Aguilar AJ Metabolism of artelinic acid to dihydroqinghaosu by human liver cytochrome P4503A | 7 | 1
|
| 11882 | 26 | 11882 1999 XENOBIOTICA 29(8):763-781
Lewis DFV; Lake BG Molecular modelling of CYP4A subfamily members based on sequence homology with CYP102 | 9 | 5
|
| 11883 | 7 | 11883 1999 XENOBIOTICA 29(8):815-826
Kashiyama E; Yokoi T; Odomi M; Kamataki T Stereoselective S-oxidation and reduction of flosequinan in rat | 0 | 0
|
| 11884 | 6 | 11884 1999 XENOBIOTICA 29(9):873-883
Hanioka N; Jinno H; Chung YS; Tanaka-Kagawa T; Nishimura T; Ando M Inhibition of rat hepatic cytochrome P450 activities by biodegradation products of 4-tert-octylphenol ethoxylate | 7 | 1
|
| 11885 | 15 | 11885 1999 XENOBIOTICA 29(9):885-898
Nakajima M; Kobayashi K; Oshima K; Shimada N; Tokudome S; Chiba K; Yokoi T Activation of phenacetin O-deethylase activity by alpha- naphthoflavone in human liver microsomes | 12 | 7
|
| 11886 | 16 | 11886 1999 XENOBIOTICA 29(12):1191-1202
Nakajima M; Suzuki M; Yamaji R; Takashina H; Shimada N; Yamazaki H; Yokoi T Isoform selective inhibition and inactivation of human cytochrome P450s by methylenedioxyphenyl compounds | 3 | 1
|
| 11887 | 11 | 11887 1999 XENOBIOTICA 29(12):1213-1226
Hanioka N; Jinno H; Tanaka-Kagawa T; Nishimura T; Ando M In vitro metabolism of simazine, atrazine and propazine by hepatic cytochrome P450 enzymes of rat, mouse and guinea pig, and oestrogenic activity of chlorotriazines and their main metabolites | 4 | 0
|
| 11888 | 2 | 11888 1999 ZEITSCHRIFT FUR GASTROENTEROLOGIE 37(5):367-378
Strohmeyer G; Weik C Drug-induced liver disease | 2 | 0
|
| 11889 | 7 | 11889 2000 ACCOUNTS OF CHEMICAL RESEARCH 33(7):449-455
Newcomb M; Toy PH Hypersensitive radical probes and the mechanisms of cytochrome P450-catalyzed hydroxylation reactions | 48 | 1
|
| 11890 | 16 | 11890 2000 ACTA BIOCHIMICA POLONICA 47(4):1093-1105
Czekaj P Phenobarbital-induced expression of cytochrome P450 genes | 0 | 0
|
| 11891 | 6 | 11891 2000 ACTA PHARMACOLOGICA SINICA 21(8):673-679
Han XM; Zhou HH Polymorphism of CYP450 and cancer susceptibility | 4 | 0
|
| 11892 | 6 | 11892 2000 ACTA PHYSIOLOGICA SCANDINAVICA 168(4):543-549
Harder DR; Roman RJ; Gebremedhin D Molecular mechanisms controlling nutritive blood flow: role of cytochrome P450 enzymes | 6 | 1
|
| 11893 | 8 | 11893 2000 ADVANCES IN CARBOHYDRATE CHEMISTRY AND BIOCHEMISTRY, VOL 55 55():175-263
El Khadem HS; Fatiadi AJ Hydrazine derivatives of carbohydrates and related compounds | 1 | 0
|
| 11894 | 3 | 11894 2000 AMERICAN JOURNAL OF CLINICAL NUTRITION 72(2):670S-674S
Jenkins RR Exercise and oxidative stress methodology: a critique | 4 | 0
|
| 11895 | 17 | 11895 2000 AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY 279(2):H857-H862
Nithipatikom K; Pratt PF; Campbell WB Determination of EETs using microbore liquid chromatography with fluorescence detection | 18 | 5
|
| 11896 | 5 | 11896 2000 AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY 279(6):L1005-L1028
Thannickal VJ; Fanburg BL Reactive oxygen species in cell signaling | 108 | 0
|
| 11897 | 19 | 11897 2000 AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY 279(6):F965-F981
Imig JD Eicosanoid regulation of the renal vasculature | 27 | 3
|
| 11898 | 10 | 11898 2000 AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 161(6):1917-1923
Kiss L; Schutte H; Mayer K; Grimm H; Padberg W; Seeger W; Grimminger F Synthesis of arachidonic acid-derived lipoxygenase end cytochrome P450 products in the intact human lung vasculature | 9 | 3
|
| 11899 | 19 | 11899 2000 AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY 22(3):360-366
Hukkanen J; Lassila A; Paivarinta K; Valanne S; Sarpo S; Hakkola J; Pelkonen O; Raunio H Induction and regulation of xenobiotic-metabolizing cytochrome P450s in the human A549 lung adenocarcinoma cell line | 19 | 7
|
| 11900 | 8 | 11900 2000 ANAESTHESIA 55(6):540-544
Chimbira W; Sweeney BP The effect of smoking on postoperative nausea and vomiting | 6 | 0
|
| # | Cited nodes | Nodes / Authors | GCS | LCS |
| 11901 | 11 | 11901 2000 ANDROLOGIA 32(4-5):255-262
Schuppe HC; Wieneke P; Donat S; Fritsche E; Kohn FM; Abel J Xenobiotic metabolism, genetic polymorphisms and male infertility | 2 | 0
|
| 11902 | 4 | 11902 2000 ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY 40():159-176
Nagata K; Yamazoe Y Pharmacogenetics of sulfotransferase | 39 | 2
|
| 11903 | 9 | 11903 2000 ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY 40():581-616
Tukey RH; Strassburg CP Human UDP-glucuronosyltransferases: Metabolism, expression, and disease | 111 | 6
|
| 11904 | 45 | 11904 2000 AQUATIC TOXICOLOGY 48(4):529-547
Snyder MJ Cytochrome P450 enzymes in aquatic invertebrates: recent advances and future directions | 14 | 3
|
| 11905 | 14 | 11905 2000 AQUATIC TOXICOLOGY 49(1-2):101-109
Cao ZJ; Hong J; Peterson RE; Aiken JM Characterization of CYP1A1 and CYP1A3 gene expression in rainbow trout (Oncorhynchus mykiss) | 6 | 2
|
| 11906 | 2 | 11906 2000 AQUATIC TOXICOLOGY 50(4):403-415
van Schanke A; Boon JP; Aardoom Y; van Leest A; van Schooten FJ; Maas L; van den Berg M; Everaarts JM Effect of a dioxin-like PCB (CB 126) on the biotransformation and genotoxicity of benzo[a]pyrene in the marine flatfish dab (Limanda limanda) | 8 | 0
|
| 11907 | 10 | 11907 2000 AQUATIC TOXICOLOGY 51(2):145-153
Teramitsu I; Yamamoto Y; Chiba I; Iwata H; Tanabe S; Fujise Y; Kazusaka A; Akahori F; Fujita S Identification of novel cytochrome P450 1A genes from five marine mammal species | 4 | 1
|
| 11908 | 10 | 11908 2000 ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS 373(1):44-55
Pikuleva IA; Tesh K; Waterman MR; Kim YC The tertiary structure of full-length bovine adrenodoxin suggests functional dimers | 23 | 7
|
| 11909 | 16 | 11909 2000 ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS 373(2):335-345
Khan KK; Halpert JR Structure-function analysis of human cytochrome P450 3A4 using 7-alkoxycoumarins as active-site probes | 16 | 3
|
| 11910 | 18 | 11910 2000 ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS 373(2):375-384
Ourlin JC; Baader M; Fraser D; Halpert JR; Meyer UA Cloning and functional expression of a first inducible avian cytochrome P450 of the CYP3A subfamily (CYP3A37) | 10 | 5
|
| 11911 | 29 | 11911 2000 ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS 374(2):269-278
Roussel F; Khan KK; Halpert JR The importance of SRS-1 residues in catalytic specificity of human cytochrome p450 3A4 | 20 | 6
|
| 11912 | 6 | 11912 2000 ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS 375(1):145-153
Kneer N; Lardy H Thyroid hormone and dehydroepiandrosterone permit gluconeogenic hormone responses in hepatocytes | 1 | 0
|
| 11913 | 9 | 11913 2000 ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS 377(1):43-48
Shumyantseva VV; Bulko TV; Bachmann TT; Bilitewski U; Schmid RD; Archakov AI Electrochemical reduction of flavocytochromes 2B4 and 1A2 and their catalytic activity | 6 | 5
|
| 11914 | 16 | 11914 2000 ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS 378(2):333-339
Kawashima H; Naganuma T; Kusunose E; Kono T; Yasumoto R; Sugimura K; Kishimoto T Human fatty acid omega-hydroxylase, CYP4A11: determination of complete genomic sequence and characterization of purified recombinant protein | 8 | 3
|
| 11915 | 14 | 11915 2000 ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS 378(2):364-376
Zhang XL; Chen LP; Hardwick JP Promoter activity and regulation of the CYP4F2 leukotriene B-4 omega-hydroxylase gene by peroxisomal proliferators and retinoic acid in HepG2 cells | 4 | 2
|
| 11916 | 13 | 11916 2000 ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS 379(1):97-108
O'Leary KA; Kasper CB Molecular basis for cell-specific regulation of the NADPH- cytochrome P450 oxidoreductase gene | 4 | 0
|
| 11917 | 14 | 11917 2000 ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS 379(1):127-136
Haudenschild C; Schalk M; Karp F; Croteau R Functional expression of regiospecific cytochrome P450 limonene hydroxylases from mint (Mentha spp.) in Escherichia coli and Saccharomyces cerevisiae | 14 | 3
|
| 11918 | 23 | 11918 2000 ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS 380(1):29-38
Kullman SW; Hamm JT; Hinton DE Identification and characterization of a cDNA encoding cytochrome P450 3A from the fresh water teleost medaka (Oryzias latipes) | 4 | 2
|
| 11919 | 19 | 11919 2000 ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS 380(1):117-125
Parimoo B; Thomas PE Epitope mapping of rat cytochrome P4502B1 using glutathione S- transferase-2B1 fusion constructs | 1 | 0
|
| 11920 | 10 | 11920 2000 ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS 380(2):367-372
Bobyleva V; Pazienza L; Muscatello U; Kneer N; Lardy H Short-term hypothermia activates hepatic mitochondrial sn- glycerol-3-phosphate dehydrogenase and thermogenic systems | 2 | 0
|
| 11921 | 16 | 11921 2000 ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS 381(1):164-170
Hayashi K; Sakaki T; Kominami S; Inouye K; Yabusaki Y Coexpression of genetically engineered fused enzyme between yeast NADPH-P450 reductase and human cytochrome P450 3A4 and human cytochrome b(5) in yeast | 9 | 4
|
| 11922 | 19 | 11922 2000 ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS 381(2):191-204
Blume N; Leonard J; Xu ZJ; Watanabe O; Remotti H; Fishman J Characterization of Cyp2d22, a novel cytochrome P450 expressed in mouse mammary cells | 1 | 0
|
| 11923 | 19 | 11923 2000 ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS 383(1):70-78
Hudecek J; Anzenbacherova E; Anzenbacher P; Munro AW; Hildebrandt P Structural similarities and differences of the heme pockets of various P450 isoforms as revealed by resonance Raman spectroscopy | 2 | 0
|
| 11924 | 9 | 11924 2000 ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS 383(1):119-127
Hsu PY; Tsai AL; Wang LH Identification of thromboxane synthase amino acid residues involved in heme-propionate binding | 2 | 0
|
| 11925 | 16 | 11925 2000 ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS 383(2):225-232
Kikuta Y; Kasyu H; Kusunose E; Kusunose M Expression and catalytic activity of mouse leukotriene B-4 omega-hydroxylase, CYP4F14 | 6 | 4
|
| 11926 | 7 | 11926 2000 ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS 384(1):143-153
MacDonald MJ; Marshall LK Mouse lacking NAD(+)-linked glycerol phosphate dehydrogenase has normal pancreatic beta cell function but abnormal metabolite pattern in skeletal muscle | 5 | 1
|
| 11927 | 17 | 11927 2000 ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS 384(2):311-318
Lekas P; Tin KL; Lee C; Prokipcak RD The human cytochrome P450 1A1 mRNA is rapidly degraded in HepG2 cells | 13 | 2
|
| 11928 | 10 | 11928 2000 ARCHIVES OF PHARMACAL RESEARCH 23(1):1-16
Kong ANT; Yu R; Chen C; Mandlekar S; Primiano T Signal transduction events elicited by natural products: Role of MAPK and caspase pathways in homeostatic response and induction of apoptosis | 34 | 1
|
| 11929 | 11 | 11929 2000 ARCHIVES OF TOXICOLOGY 73(12):625-631
Hanioka N; Jinno H; Chung YS; Nishimura T; Tanaka-Kagawa T; Ando M Effect of 4-tert-octylphenol on cytochrome P450 enzymes in rat liver | 3 | 1
|
| 11930 | 3 | 11930 2000 ARCHIVES OF TOXICOLOGY 74(7):379-387
Laube B; Winkler S; Ladstetter B; Scheller T; Schwarz LR Establishment of a novel in vitro system for studying the interaction of xenobiotic metabolism of liver and intestinal microflora | 0 | 0
|
| 11931 | 7 | 11931 2000 ARCHIVES OF TOXICOLOGY 74(7):397-403
Pons F; Haag M; Corcos L; Bonnet P; Guillouzo A; Lugnier A; Frossard N Inhalation of toluene diisocyanate affects cytochrome P4502B1 expression in rat lung | 5 | 3
|
| 11932 | 3 | 11932 2000 ARCHIVES OF TOXICOLOGY 74(7):415-420
Bertini S; Del Carratore R; Giorgi M; Bronzetti G; Della Croce C Genotoxic and mono-oxygenase system effects of the fungicide maneb | 0 | 0
|
| 11933 | 3 | 11933 2000 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 267(1):184-189
Dalton TP; Dieter MZ; Matlib RS; Childs NL; Shertzer HG; Genter MB; Nebert DW Targeted knockout of Cyp1a1 gene does not alter hepatic constitutive expression of other genes in the mouse [Ah] battery | 15 | 5
|
| 11934 | 9 | 11934 2000 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 267(2):572-576
Guigal N; Seree E; Bourgarel-Rey V; Barra Y Induction of CYP1A1 by serum independent of AhR pathway | 7 | 0
|
| 11935 | 7 | 11935 2000 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 268(3):677-682
Tares S; Berge JB; Amichot M Cloning and expression of cytochrome P450 genes belonging to the CYP4 family and to a novel family, CYP48, in two hymenopteran insects, Trichogramma cacoeciae and Apis mellifera | 1 | 1
|
| 11936 | 7 | 11936 2000 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 268(3):740-744
Lei CH; Wollenberger U; Jung C; Scheller FW Clay-bridged electron transfer between cytochrome P450(cam) and electrode | 8 | 2
|
| 11937 | 7 | 11937 2000 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 269(2):393-396
Mushiroda T; Ariyoshi N; Kimura K; Takahara E; Nagata O; Kato H; Kamataki T A high-level expression of CYP2A in the lung of the suncus (Suncus murinus) and its role in the activation of 4- (methylnitrosamino)-1-(3-pyridyl)-1-butanone | 0 | 0
|
| 11938 | 12 | 11938 2000 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 269(2):623-627
Inoue E; Takahashi Y; Imai Y; Kamataki T Development of bacterial expression system with high yield of CYP3A7, a human fetus-specific form of cytochrome P450 | 2 | 2
|
| 11939 | 10 | 11939 2000 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 269(3):737-742
Simgen B; Contzen J; Schwarzer R; Bernhardt R; Jung C Substrate binding to 15 beta-hydroxylase (CYP106A2) probed by FT infrared spectroscopic studies of the iron ligand CO stretch vibration | 4 | 1
|
| 11940 | 2 | 11940 2000 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 271(3):788-795
Lee PL; Halloran C; Cross AR; Beutler E NADH-ferric reductase activity associated with dihydropteridine reductase | 5 | 0
|
| 11941 | 12 | 11941 2000 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 273(3):799-804
Yoshida Y; Aoyama Y; Noshiro M; Gotoh O Sterol 14-demethylase P450 (CYP51) provides a breakthrough for the discussion on the evolution of cytochrome P450 gene superfamily | 13 | 4
|
| 11942 | 23 | 11942 2000 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 273(3):1132-1137
Maibeche-Coisne M; Monti-Dedieu L; Aragon S; Dauphin-Villemant C A new cytochrome P450 from Drosophila melanogaster, CYP4G15, expressed in the nervous system | 3 | 0
|
| 11943 | 9 | 11943 2000 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 276(2):762-766
LeLean JE; Moon N; Dunham WR; Coon MJ EPR spectrometry of cytochrome P4502B4: Effects of mutations and substrate binding | 3 | 1
|
| 11944 | 8 | 11944 2000 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 277(3):594-598
Jeong HG; Kim JY; Choi CY Down-regulation of murine Cyp1a-1 in mouse hepatoma Hepa-1c1c7 cells by bisphenol A | 2 | 0
|
| 11945 | 7 | 11945 2000 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 279(1):288-292
Jarukamjorn K; Sakuma T; Nemoto N Discriminating activation of CYP2B9 expression in male C57BL/6 mouse liver by beta-estradiol | 4 | 0
|
| 11946 | 7 | 11946 2000 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 279(2):708-711
Taylor M; Lamb DC; Cannell RJP; Dawson MJ; Kelly SL Cofactor recycling with immobilized heterologous cytochrome P450 105D1 (CYP105D1) | 1 | 1
|
| 11947 | 71 | 11947 2000 BIOCHEMICAL JOURNAL 347():321-337
Honkakoski P; Negishi M Regulation of cytochrome P450 (CYP) genes by nuclear receptors | 68 | 14
|
| 11948 | 21 | 11948 2000 BIOCHEMICAL PHARMACOLOGY 59(1):65-85
Nebert DW; Roe AL; Dieter MZ; Solis WA; Yang Y; Dalton TP Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis | 95 | 7
|
| 11949 | 9 | 11949 2000 BIOCHEMICAL PHARMACOLOGY 59(5):583-589
Oinonen T; Ronis M; Wigell T; Tohmo K; Badger T; Lindros KO Growth hormone-regulated periportal expression of CYP2C7 in rat liver | 1 | 0
|
| 11950 | 10 | 11950 2000 BIOCHEMICAL PHARMACOLOGY 59(8):997-1005
Puga A; Barnes SJ; Chang CY; Zhu H; Nephew KP; Khan SA; Shertzer HG Activation of transcription factors activator protein-1 and nuclear factor-kappa B by 2,3,7,8-tetrachlorodibenzo-p-dioxin | 23 | 0
|
| 11951 | 28 | 11951 2000 BIOCHEMICAL PHARMACOLOGY 59(10):1277-1287
Kawai M; Bandiera SM; Chang TKH; Bellward GD Growth hormone regulation and developmental expression of rat hepatic CYP3A18, CYP3A9, and CYP3A2 | 7 | 0
|
| 11952 | 15 | 11952 2000 BIOCHEMICAL PHARMACOLOGY 60(3):293-306
Lewis DFV On the recognition of mammalian microsomal cytochrome P450 substrates and their characteristics - Towards the prediction of human P450 substrate specificity and metabolism | 32 | 7
|
| 11953 | 10 | 11953 2000 BIOCHEMICAL PHARMACOLOGY 60(6):857-863
Ueno T; Tamura S; Frels WI; Shou M; Gonzalez FJ; Kimura S A transgenic mouse expressing human CYP1A2 in the pancreas | 3 | 0
|
| 11954 | 7 | 11954 2000 BIOCHEMISTRY 39(10):2484-2498
Chang YT; Loew G Homology modeling, molecular dynamics simulations, and analysis of CYP119, a P450 enzyme from extreme acidothermophilic archaeon Sulfolobus solfataricus | 11 | 2
|
| 11955 | 31 | 11955 2000 BIOCHEMISTRY 39(17):5196-5205
Helvig C; Capdevila JH Biochemical characterization of rat P4502C11 fused to rat or bacterial NADPH-P450 reductase domains | 3 | 3
|
| 11956 | 16 | 11956 2000 BIOCHEMISTRY 39(19):5731-5737
Smith SV; Koley AP; Dai RK; Robinson RC; Leong H; Markowitz A; Friedman FK Conformational modulation of human cytochrome P450 2E1 by ethanol and other substrates: A CO flash photolysis study | 6 | 1
|
| 11957 | 26 | 11957 2000 BIOCHEMISTRY 39(20):5929-5939
Hosea NA; Miller GP; Guengerich FP Elucidation of distinct ligand binding sites for cytochrome P450 3A4 | 53 | 17
|
| 11958 | 6 | 11958 2000 BIOCHEMISTRY 39(20):5961-5970
Ihara M; Takahashi S; Ishimori K; Morishima I Functions of fluctuation in the heme-binding loops of cytochrome b(5) revealed in the process of heme incorporation | 6 | 0
|
| 11959 | 34 | 11959 2000 BIOCHEMISTRY 39(21):6489-6497
Davydov DR; Kariakin AA; Petushkova NA; Peterson JA Association of cytochromes P450 with their reductases: Opposite sign of the electrostatic interactions in P450BM-3 as compared with the microsomal 2B4 system | 6 | 3
|
| 11960 | 9 | 11960 2000 BIOCHEMISTRY 39(24):7117-7130
Arnesano F; Banci L; Bertini I; Koulougliotis D; Monti A Monitoring mobility in the early steps of unfolding: The case of oxidized cytochrome b(5) in the presence of 2 M guanidinium chloride | 7 | 0
|
| 11961 | 4 | 11961 2000 BIOCHEMISTRY 39(30):8859-8869
Reynolds CM; Poole LB Attachment of the N-terminal domain of Salmonella typhimurium AhpF to Escherichia coli thioredoxin reductase confers AhpC reductase activity but does not affect thioredoxin reductase activity | 12 | 0
|
| 11962 | 12 | 11962 2000 BIOCHEMISTRY 39(31):9419-9429
Haines DC; Sevrioukova IF; Peterson JA The FMN-binding domain of cytochrome P450BM-3: Resolution, reconstitution, and flavin analogue substitution | 3 | 2
|
| 11963 | 9 | 11963 2000 BIOCHEMISTRY 39(36):10986-10995
Ziegler GA; Schulz GE Crystal structures of adrenodoxin reductase in complex with NADP(+) and NADPH suggesting a mechanism for the electron transfer of an enzyme family | 16 | 2
|
| 11964 | 11 | 11964 2000 BIOCHEMISTRY 39(41):12699-12707
Murataliev MB; Feyereisen R Functional interactions in cytochrome P450(BM3). Evidence that NADP(H) binding controls redox potentials of the flavin cofactors | 2 | 0
|
| 11965 | 11 | 11965 2000 BIOCHEMISTRY 39(45):13817-13824
Gillam EMJ; Notley LM; Cai HL; De Voss JJ; Guengerich FP Oxidation of indole by cytochrome P450 enzymes | 14 | 4
|
| 11966 | 23 | 11966 2000 BIOCHEMISTRY 39(49):15110-15120
Loughran PA; Roman LJ; Aitken AE; Miller RT; Masters BSS Identification of unique amino acids that modulate CYP4A7 activity | 6 | 3
|
| 11967 | 2 | 11967 2000 BIOCHEMISTRY-MOSCOW 65(8):972-975
Sumbayev VV In vitro effects of corticosteroids, DDT, and 4,9- dichlorodibenzodioxin on rat liver xanthine oxidase activity. Interactions between xanthine oxidase and cytochrome P450 in rat liver in vivo | 1 | 0
|
| 11968 | 5 | 11968 2000 BIOCHEMISTRY-MOSCOW 65(10):1206-1211
Kovaleva IE; Grivennikov SI; Luzikov VN On the effect of cholesterol on the fate of CYP11A1 imported into yeast mitochondria in vivo | 0 | 0
|
| 11969 | 13 | 11969 2000 BIOCHEMISTRY-MOSCOW 65(12):1362-1366
Novikova LA; Nazarov PA; Saveliev AS; Drutsa VL; Sergeev VN; Miller WL; Luzikov VN Interaction of catalytic domains in cytochrome P450scc- adrenodoxin reductase-adrenodoxin fusion protein imported into yeast mitochondria | 1 | 1
|
| 11970 | 50 | 11970 2000 BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS 1460(2-3):353-374
Lewis DFV; Hlavica P Interactions between redox partners in various cytochrome P450 systems: functional and structural aspects | 8 | 3
|
| 11971 | 1 | 11971 2000 BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES 1465(1-2):79-103
Theodoulou FL Plant ABC transporters | 32 | 0
|
| 11972 | 9 | 11972 2000 BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS 1529(1-3):126-135
Russell DW Oxysterol biosynthetic enzymes | 27 | 0
|
| 11973 | 17 | 11973 2000 BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY 1476(2):253-264
Cao PR; Bulow H; Dumas B; Bernhardt R Construction and characterization of a catalytic fusion protein system: P-45011(beta)-adrenodoxin reductase-adrenodoxin | 4 | 3
|
| 11974 | 74 | 11974 2000 BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY 1543(2):383-407
Miles CS; Ost TWB; Noble MA; Munro AW; Chapman SK Protein engineering of cytochromes P-450 | 21 | 9
|
| 11975 | 7 | 11975 2000 BIOFIZIKA 45(6):1013-1018
Shumyantseva VV; Bulko TV; Schmid RD; Archakov AI Photoreduction of flavocytochrome P4502B4 | 1 | 0
|
| 11976 | 10 | 11976 2000 BIOLOGICAL CHEMISTRY 381(7):611-614
Weitzel JM; Grott S; Radtke C; Kutz S; Seitz HJ Multiple promoters direct the tissue-specific expression of rat mitochondrial glycerol-3-phosphate dehydrogenase | 4 | 1
|
| 11977 | 2 | 11977 2000 BIOMARKERS 5(2):81-107
Neghab M; Stacey NH Serum bile acids as a sensitive biological marker for evaluating hepatic effects of organic solvents | 2 | 0
|
| 11978 | 2 | 11978 2000 BIOMETALS 13(1):23-28
Sugimori D; Ichimata T; Ikeda A; Nakamura S Purification and characterization of a ferredoxin from Haloarcula japonica strain TR-1 | 1 | 1
|
| 11979 | 2 | 11979 2000 BIOORGANICHESKAYA KHIMIYA 26(2):97-111
Preobrazhenskaya MN; Korolev AM Indole derivatives in vegetables of the Cruciferae family | 1 | 0
|
| 11980 | 6 | 11980 2000 BIOTECHNOLOGY LETTERS 22(1):3-8
Engler KH; Kelly SL; Coker RD; Evans IH Toxin-binding properties of cytochrome P450 in Saccharomyces cerevisiae and Kluyveromyces marxianus | 1 | 0
|
| 11981 | 9 | 11981 2000 BIOTECHNOLOGY PROGRESS 16(4):610-616
Mayhew MP; Reipa V; Holden MJ; Vilker VL Improving the cytochrome P450 enzyme system for electrode- driven biocatalysis of styrene epoxidation | 14 | 3
|
| 11982 | 6 | 11982 2000 BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 49():35S-42S
Prakash C; Kamel A; Cui D; Whalen RD; Miceli JJ; Tweedie D Identification of the major human liver cytochrome P450 isoform(s) responsible for the formation of the primary metabolites of ziprasidone and prediction of possible drug interactions | 26 | 0
|
| 11983 | 10 | 11983 2000 BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 49(2):145-151
Ou-Yang DS; Huang SL; Wang W; Xie HG; Xu ZH; Shu Y; Zhou HH Phenotypic polymorphism and gender-related differences of CYP1A2 activity in a Chinese population | 15 | 0
|
| 11984 | 8 | 11984 2000 BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 49(3):244-253
Ohyama K; Nakajima M; Suzuki M; Shimada N; Yamazaki H; Yokoi T Inhibitory effects of amiodarone and its N-deethylated metabolite on human cytochrome P450 activities: Prediction of in vivo drug interactions | 13 | 2
|
| 11985 | 15 | 11985 2000 BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 50(6):573-580
Ong CE; Coulter S; Birkett DJ; Bhasker CR; Miners JO The xenobiotic inhibitor profile of cytochrome P4502C8 | 9 | 1
|
| 11986 | 9 | 11986 2000 BRITISH JOURNAL OF PHARMACOLOGY 129(3):547-554
Fearon IM; Ball SG; Peers C Clotrimazole inhibits the recombinant human cardiac L-type Ca2+ channel alpha(1C) subunit | 4 | 0
|
| 11987 | 9 | 11987 2000 BRITISH JOURNAL OF PHARMACOLOGY 130(8):1745-1752
Thum T; Borlak J Cytochrome P450 mono-oxygenase gene expression and protein activity in cultures of adult cardiomyocytes of the rat | 7 | 1
|
| 11988 | 16 | 11988 2000 CANCER RESEARCH 60(6):1604-1608
Rubin GL; Zhao Y; Kalus AM; Simpson ER Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: Possible implications for breast cancer therapy | 37 | 2
|
| 11989 | 10 | 11989 2000 CANCER RESEARCH 60(12):3232-3238
Quintieri L; Rosato A; Napoli E; Sola F; Geroni C; Floreani M; Zanovello P In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: Role of cytochrome P450 3A | 9 | 3
|
| 11990 | 16 | 11990 2000 CANCER RESEARCH 60(17):4667-4677
Williams JA; Phillips DH Mammary expression of xenobiotic metabolizing enzymes and their potential role in breast cancer | 27 | 2
|
| 11991 | 15 | 11991 2000 CARCINOGENESIS 21(3):345-351
Guengerich FP Metabolism of chemical carcinogens | 24 | 2
|
| 11992 | 3 | 11992 2000 CARCINOGENESIS 21(4):669-676
Alexandrie AK; Warholm M; Carstensen U; Axmon A; Hagmar L; Levin JO; Ostman C; Rannug A CYP1A1 and GSTM1 polymorphisms affect urinary 1-hydroxypyrene levels after PAH exposure | 21 | 0
|
| 11993 | 3 | 11993 2000 CARCINOGENESIS 21(6):1163-1166
Schabath MB; Spitz MR; Zhang XM; Delclos GL; Wu XF Genetic variants of myeloperoxidase and lung cancer risk | 28 | 0
|
| 11994 | 13 | 11994 2000 CARCINOGENESIS 21(6):1227-1232
Kushida H; Fujita K; Suzuki A; Yamada M; Endo T; Nohmi T; Kamataki T Metabolic activation of N-alkylnitrosamines in genetically engineered Salmonella typhimurium expressing CYP2E1 or CYP2A6 together with human NADPH-cytochrome P450 reductase | 19 | 9
|
| 11995 | 10 | 11995 2000 CARCINOGENESIS 21(8):1559-1566
Teiber JF; Hollenberg PF Identification of the human liver microsomal cytochrome P450s involved in the metabolism of N-nitrosodi-n-propylamine | 3 | 3
|
| 11996 | 2 | 11996 2000 CELL BIOLOGY INTERNATIONAL 24(8):569-580
Gilbert D; Lloyd D The living cell: A complex autodynamic multi-oscillator system? | 3 | 0
|
| 11997 | 2 | 11997 2000 CELLULAR AND MOLECULAR BIOLOGY 46(7):1191-1212
Krieg R; Halbhuber KJ; Oehring H Novel chromogenic substrates with metal chelating properties for the histochemical detection of peroxidasic activity, derived from 3-amino-9-ethylcarbazole (AEC) and 3,6-diamino-9- ethylcarbazole | 0 | 0
|
| 11998 | 30 | 11998 2000 CELLULAR AND MOLECULAR LIFE SCIENCES 57(3):487-499
Dai R; Pincus MR; Friedman FK Molecular modeling of mammalian cytochrome P450s | 13 | 3
|
| 11999 | 18 | 11999 2000 CHEMICAL RESEARCH IN TOXICOLOGY 13(12):1349-1359
Goosen TC; Kent UM; Brand L; Hollenberg PF Inactivation of cytochrome P4502B1 by benzyl isothiocyanate, a chemopreventative agent from cruciferous vegetables | 4 | 1
|
| 12000 | 3 | 12000 2000 CHEMICO-BIOLOGICAL INTERACTIONS 126(1):45-61
Soucek P; Ivan G; Pavel S Effect of the microsomal system on interconversions between hydroquinone, benzoquinone, oxygen activation, and lipid peroxidation | 3 | 0
|